<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bull World Health Organ</journal-id><journal-id journal-id-type="iso-abbrev">Bull. World Health Organ</journal-id><journal-id journal-id-type="publisher-id">BLT</journal-id><journal-title-group><journal-title>Bulletin of the World Health Organization</journal-title></journal-title-group><issn pub-type="ppub">0042-9686</issn><issn pub-type="epub">1564-0604</issn><publisher><publisher-name>World Health Organization</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29531414</article-id><article-id pub-id-type="pmc">5840627</article-id><article-id pub-id-type="publisher-id">BLT.17.198366</article-id><article-id pub-id-type="doi">10.2471/BLT.17.198366</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Ward-based clinical pharmacists and hospital readmission: a non-randomized controlled trial in Sri Lanka</article-title><trans-title-group xml:lang="fr"><trans-title xml:lang="fr">Pr&#x000e9;sence de pharmaciens cliniciens dans les &#x000e9;tages et r&#x000e9;admissions &#x000e0; l'h&#x000f4;pital: un essai contr&#x000f4;l&#x000e9; non randomis&#x000e9; au Sri Lanka</trans-title></trans-title-group><trans-title-group xml:lang="es"><trans-title xml:lang="es">Farmac&#x000e9;uticos cl&#x000ed;nicos en planta y readmisi&#x000f3;n hospitalaria: un ensayo no aleatorizado controlado en Sri Lanka</trans-title></trans-title-group><trans-title-group xml:lang="ar"><trans-title xml:lang="ar">&#x00627;&#x00644;&#x00635;&#x0064a;&#x00627;&#x0062f;&#x00644;&#x00629; &#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c;&#x0064a;&#x00648;&#x00646; &#x00627;&#x00644;&#x00645;&#x0062e;&#x0062a;&#x00635;&#x00648;&#x00646; &#x00628;&#x00645;&#x0062a;&#x00627;&#x00628;&#x00639;&#x00629; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00627;&#x00644;&#x00646;&#x00632;&#x00644;&#x00627;&#x00621; &#x00628;&#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x0064a;&#x00627;&#x0062a; &#x00648;&#x00639;&#x00648;&#x0062f;&#x00629; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00644;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00634;&#x00641;&#x00627;&#x00621; &#x0062f;&#x00627;&#x0062e;&#x00644;&#x000a0;&#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x0064a;&#x00627;&#x0062a;: &#x0062a;&#x0062c;&#x00631;&#x00628;&#x00629; &#x0063a;&#x0064a;&#x00631;&#x000a0;&#x00645;&#x00639;&#x00634;&#x00627;&#x00629; &#x00645;&#x00636;&#x00628;&#x00637;&#x00629;&#x000a0;&#x00628;&#x00627;&#x00644;&#x00634;&#x00648;&#x00627;&#x00647;&#x0062f; &#x00641;&#x0064a;&#x000a0;&#x00633;&#x00631;&#x0064a;&#x000a0;&#x00644;&#x00627;&#x00646;&#x00643;&#x00627; </trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title xml:lang="zh">&#x057fa;&#x04e8e;&#x075c5;&#x0623f;&#x07684;&#x04e34;&#x05e8a;&#x0836f;&#x05242;&#x05e08;&#x0548c;&#x08fd4;&#x09662;&#x06cbb;&#x07597;&#x0ff1a;&#x065af;&#x091cc;&#x05170;&#x05361;&#x0975e;&#x0968f;&#x0673a;&#x05bf9;&#x07167;&#x08bd5;&#x09a8c;</trans-title></trans-title-group><trans-title-group xml:lang="ru"><trans-title xml:lang="ru">&#x00411;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x00438;&#x00447;&#x0043d;&#x0044b;&#x00435; &#x0043a;&#x0043b;&#x00438;&#x0043d;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00435; &#x00444;&#x00430;&#x00440;&#x0043c;&#x00430;&#x00446;&#x00435;&#x00432;&#x00442;&#x0044b; &#x00438; &#x0043f;&#x0043e;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0043d;&#x00430;&#x0044f; &#x00433;&#x0043e;&#x00441;&#x0043f;&#x00438;&#x00442;&#x00430;&#x0043b;&#x00438;&#x00437;&#x00430;&#x00446;&#x00438;&#x0044f;: &#x0043d;&#x00435;&#x00440;&#x00430;&#x0043d;&#x00434;&#x0043e;&#x0043c;&#x00438;&#x00437;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0043e;&#x00435; &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x00438;&#x00440;&#x00443;&#x00435;&#x0043c;&#x0043e;&#x00435; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00435; &#x00432; &#x00428;&#x00440;&#x00438;-&#x0041b;&#x00430;&#x0043d;&#x0043a;&#x00435;</trans-title></trans-title-group><alt-title alt-title-type="author-running-head">Lelwala Guruge Thushani Shanika et al.</alt-title><alt-title alt-title-type="title-running-head">Clinical pharmacy services for noncommunicable diseases</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Shanika</surname><given-names>Lelwala Guruge Thushani</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jayamanne</surname><given-names>Shaluka</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wijekoon</surname><given-names>Chandrani Nirmala</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Coombes</surname><given-names>Judith</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Perera</surname><given-names>Dhineli</given-names></name><xref ref-type="aff" rid="aff5"><sup>e</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mohamed</surname><given-names>Fahim</given-names></name><xref ref-type="aff" rid="aff6"><sup>f</sup></xref></contrib><contrib contrib-type="author"><name><surname>Coombes</surname><given-names>Ian</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>De Silva</surname><given-names>Hithanadura Asita</given-names></name><xref ref-type="aff" rid="aff7"><sup>g</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dawson</surname><given-names>Andrew Hamilton</given-names></name><xref ref-type="aff" rid="aff8"><sup>h</sup></xref></contrib><aff id="aff1"><label>a</label>Department of Allied Health Science, Faculty of Medical Sciences, University of Sri Jayewardenapura, Nugegoda, <country>Sri Lanka</country>.</aff><aff id="aff2"><label>b</label>Faculty of Medicine, University of Kelaniya, Ragama, <country>Sri Lanka</country>.</aff><aff id="aff3"><label>c</label>Faculty of Medical Sciences, University of Sri Jayewardenapura, Nugegoda, <country>Sri Lanka</country>.</aff><aff id="aff4"><label>d</label>School of Pharmacy, <institution>University of Queensland</institution>, <addr-line>Brisbane</addr-line>, <country>Australia</country>.</aff><aff id="aff5"><label>e</label>Department of Pharmacy, Austin Health, <addr-line>Melbourne</addr-line>, <country>Australia</country>.</aff><aff id="aff6"><label>f</label>Faculty of Medicine, <institution>University of Peradeniya</institution>, <addr-line>Peradeniya</addr-line>, <country>Sri Lanka</country>.</aff><aff id="aff7"><label>g</label>Faculty of Medicine, University of Kelaniya, Ragama, <country>Sri Lanka</country>.</aff><aff id="aff8"><label>h</label>Faculty of Medicine, <institution>University of Sydney</institution>, <addr-line>Sydney</addr-line>, <country>Australia</country>.</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to Lelwala Guruge Thushani Shanika (email: <email xlink:href="thushani@sjp.ac.lk">thushani@sjp.ac.lk</email>).</corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>3</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>30</day><month>11</month><year>2017</year></pub-date><volume>96</volume><issue>3</issue><fpage>155</fpage><lpage>164</lpage><history><date date-type="received"><day>10</day><month>6</month><year>2017</year></date><date date-type="rev-recd"><day>05</day><month>11</month><year>2017</year></date><date date-type="accepted"><day>06</day><month>11</month><year>2017</year></date></history><permissions><copyright-statement>(c) 2018 The authors; licensee World Health Organization.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/igo/legalcode">http://creativecommons.org/licenses/by/3.0/igo/legalcode</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.</license-p></license></permissions><abstract><title>Abstract</title><sec><title>Objective</title><p>To assess if a ward-based clinical pharmacy service resolving drug-related problems improved medication appropriateness at discharge and prevented drug-related hospital readmissions.</p></sec><sec><title>Method</title><p>Between March and September 2013, we recruited patients with noncommunicable diseases in a Sri Lankan tertiary-care hospital, for a non-randomized controlled clinical trial. The intervention group received usual care and clinical pharmacy service. The intervention pharmacist made prospective medication reviews, identified drug-related problems and discussed recommendations with the health-care team and patients. At discharge, the patients received oral and written medication information. The control group received usual care. We used the medication appropriateness index to assess appropriateness of prescribing at discharge. During a six-month follow-up period, a pharmacist interviewed patients to identify drug-related hospital readmissions.</p></sec><sec><title>Results</title><p>Data from 361 patients in the intervention group and 354 patients in the control group were available for analysis. Resolutions of drug-related problems were higher in the intervention group than in the control group (57.6%; 592/1027, versus 13.2%; 161/1217; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) and the medication was more appropriate in the intervention group. Mean score of medication appropriateness index per patient was 1.25 versus 4.3 in the control group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). Patients in the intervention group were less likely to be readmitted due to drug-related problems (44 patients of 311 versus 93 of 311 in the control group; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001).</p></sec><sec><title>Conclusion</title><p>A ward-based clinical pharmacy service improved appropriate prescribing, reduced drug-related problems and readmissions for patients with noncommunicable diseases. Implementation of such a service could improve health care in Sri Lanka and similar settings.</p></sec></abstract><trans-abstract xml:lang="fr"><title>R&#x000e9;sum&#x000e9;</title><sec><title>Objectif</title><p><bold><italic>&#x000c9;valuer si la pr&#x000e9;sence dans les &#x000e9;tages d'un service de pharmacie clinique r&#x000e9;solvant les probl&#x000e8;mes li&#x000e9;s aux m&#x000e9;dicaments a permis de mieux adapter les prescriptions m&#x000e9;dicales &#x000e0; la sortie de l'h&#x000f4;pital et d'emp&#x000ea;cher les r&#x000e9;admissions dues aux m&#x000e9;dicaments.</italic></bold></p></sec><sec><title>M&#x000e9;thodes</title><p><bold><italic>Entre mars et septembre&#x000a0;2013, nous avons recrut&#x000e9; des patients atteints de maladies non transmissibles dans un h&#x000f4;pital de soins tertiaires du Sri&#x000a0;Lanka afin de participer &#x000e0; un essai clinique contr&#x000f4;l&#x000e9; non randomis&#x000e9;. Le groupe exp&#x000e9;rimental a b&#x000e9;n&#x000e9;fici&#x000e9; de la prise en charge habituelle et d'un service de pharmacie clinique. Le pharmacien de l'essai a fait un examen prospectif des traitements, a rep&#x000e9;r&#x000e9; les probl&#x000e8;mes li&#x000e9;s aux m&#x000e9;dicaments et a discut&#x000e9; des recommandations avec l'&#x000e9;quipe de soins et les patients. &#x000c0; leur sortie de l'h&#x000f4;pital, les patients ont &#x000e9;t&#x000e9; inform&#x000e9;s oralement et par &#x000e9;crit au sujet du traitement prescrit. Le groupe t&#x000e9;moin a b&#x000e9;n&#x000e9;fici&#x000e9; de la prise en charge habituelle. Nous avons utilis&#x000e9; le Medication Appropriateness Index (indice de pertinence des traitements) pour &#x000e9;valuer la pertinence des prescriptions &#x000e0; la sortie de l'h&#x000f4;pital. Pendant une p&#x000e9;riode de suivi de six mois, un pharmacien a interrog&#x000e9; les patients afin de d&#x000e9;terminer si les r&#x000e9;admissions &#x000e0; l'h&#x000f4;pital &#x000e9;taient dues &#x000e0; des m&#x000e9;dicaments.</italic></bold></p></sec><sec><title>R&#x000e9;sultats</title><p><bold><italic>Nous avons pu analyser les donn&#x000e9;es de 361&#x000a0;patients du groupe exp&#x000e9;rimental et de 354&#x000a0;patients du groupe t&#x000e9;moin. Les probl&#x000e8;mes li&#x000e9;s aux m&#x000e9;dicaments ont &#x000e9;t&#x000e9; davantage r&#x000e9;solus dans le groupe exp&#x000e9;rimental que dans le groupe t&#x000e9;moin (57,6%; 592/1027, contre 13,2%; 161/1217; P&#x000a0;&#x0003c;&#x000a0;0,001) et les traitements &#x000e9;taient plus adapt&#x000e9;s dans le groupe exp&#x000e9;rimental. Le score moyen par patient du Medication Appropriateness Index &#x000e9;tait de 1,25 contre 4,3 dans le groupe t&#x000e9;moin (P&#x000a0;&#x0003c;&#x000a0;0,001). Les patients &#x000e9;taient moins nombreux &#x000e0; &#x000ea;tre r&#x000e9;admis pour des probl&#x000e8;mes li&#x000e9;s &#x000e0; des m&#x000e9;dicaments dans le groupe exp&#x000e9;rimental (44&#x000a0;patients sur 311 contre 93 sur 311 dans le groupe t&#x000e9;moin; P&#x000a0;&#x0003c;&#x000a0;0,001).</italic></bold></p></sec><sec><title>Conclusion</title><p><bold><italic>La pr&#x000e9;sence d'un service de pharmacie clinique dans les &#x000e9;tages a permis d'am&#x000e9;liorer la pertinence des prescriptions et de r&#x000e9;duire les probl&#x000e8;mes li&#x000e9;s aux m&#x000e9;dicaments ainsi que les r&#x000e9;admissions pour les patients atteints de maladies non transmissibles. La mise en place d'un service de ce type pourrait am&#x000e9;liorer la prise en charge m&#x000e9;dicale au Sri&#x000a0;Lanka et dans des r&#x000e9;gions similaires.</italic></bold></p></sec></trans-abstract><trans-abstract xml:lang="es"><title>Resumen</title><sec><title>Objetivo</title><p>Evaluar si un servicio de farmacia cl&#x000ed;nica en planta para la resoluci&#x000f3;n de los problemas relacionados con los medicamentos, mejor&#x000f3; la adecuaci&#x000f3;n de la medicaci&#x000f3;n en el momento del alta y evit&#x000f3; las readmisiones hospitalarias relacionadas con los medicamentos.</p></sec><sec><title>M&#x000e9;todos</title><p>Entre marzo y septiembre de 2013, captamos pacientes con enfermedades no contagiosas en un hospital de atenci&#x000f3;n terciaria de Sri Lanka, para un ensayo cl&#x000ed;nico no aleatorizado controlado. El grupo de intervenci&#x000f3;n recibi&#x000f3; la atenci&#x000f3;n habitual y servicios de farmacia cl&#x000ed;nica. El farmac&#x000e9;utico de intervenci&#x000f3;n realiz&#x000f3; las revisiones prospectivas de la medicaci&#x000f3;n, identific&#x000f3; los problemas relacionados con los medicamentos y discuti&#x000f3; las recomendaciones con el equipo de atenci&#x000f3;n m&#x000e9;dica y los pacientes. En el momento del alta, los pacientes recibieron informaci&#x000f3;n oral y escrita sobre los medicamentos. El grupo de control recibi&#x000f3; la atenci&#x000f3;n habitual. Usamos el &#x000ed;ndice de adecuaci&#x000f3;n de la medicaci&#x000f3;n para evaluar la adecuaci&#x000f3;n de la prescripci&#x000f3;n en el momento del alta. Durante un periodo de seguimiento de seis meses, un farmac&#x000e9;utico entrevist&#x000f3; a los pacientes para identificar las readmisiones hospitalarias relacionadas con los medicamentos.</p></sec><sec><title>Resultados</title><p>Los datos de 361 pacientes en el grupo de intervenci&#x000f3;n y de 354 pacientes en el grupo de control estuvieron disponibles para el an&#x000e1;lisis. Las resoluciones de los problemas relacionados con los medicamentos fueron m&#x000e1;s altas en el grupo de intervenci&#x000f3;n que en el grupo de control (57,6%; 592/1027, frente a 13,2%; 161/1217; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0,001) y la medicaci&#x000f3;n fue m&#x000e1;s adecuada en el grupo de intervenci&#x000f3;n. La puntuaci&#x000f3;n media del &#x000ed;ndice de adecuaci&#x000f3;n de la medicaci&#x000f3;n por paciente fue de 1,25 frente a 4,3 en el grupo de control (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0,001). Los pacientes en el grupo de intervenci&#x000f3;n ten&#x000ed;an menos probabilidades de ser readmitidos a causa de problemas relacionados con la medicaci&#x000f3;n (44 pacientes de 311 frente a 93 de 311 en el grupo de control, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0,001).</p></sec><sec><title>Conclusi&#x000f3;n</title><p>Un servicio de farmacia cl&#x000ed;nica en planta mejor&#x000f3; la prescripci&#x000f3;n adecuada de medicamentos, redujo los problemas relacionados con los medicamentos y las readmisiones de pacientes con enfermedades no contagiosas. La implementaci&#x000f3;n de dicho servicio podr&#x000ed;a mejorar la atenci&#x000f3;n m&#x000e9;dica en Sri Lanka y en entornos similares.</p></sec></trans-abstract><trans-abstract xml:lang="ar"><title>&#x00645;&#x00644;&#x0062e;&#x00635; </title><sec><title>&#x00627;&#x00644;&#x0063a;&#x00631;&#x00636; </title><p>&#x0062a;&#x00642;&#x0064a;&#x0064a;&#x00645; &#x0062f;&#x00648;&#x00631; &#x0062e;&#x0062f;&#x00645;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00635;&#x0064a;&#x0062f;&#x00644;&#x00629; &#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x00642;&#x0062f;&#x00645;&#x00629; &#x00644;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00627;&#x00644;&#x00646;&#x00632;&#x00644;&#x00627;&#x00621; &#x00628;&#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x0064a;&#x00627;&#x0062a; &#x00628;&#x00645;&#x00627; &#x0062a;&#x00647;&#x0062f;&#x00641; &#x00625;&#x00644;&#x0064a;&#x00647; &#x00645;&#x00646; &#x0062d;&#x00644; &#x00627;&#x00644;&#x00645;&#x00634;&#x00643;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x0062a;&#x00639;&#x00644;&#x00642;&#x00629; &#x00628;&#x00627;&#x00644;&#x0062f;&#x00648;&#x00627;&#x00621; &#x00648;&#x0062d;&#x00642;&#x0064a;&#x00642;&#x00629; &#x00625;&#x00633;&#x00647;&#x00627;&#x00645; &#x0062a;&#x00644;&#x00643; &#x00627;&#x00644;&#x0062e;&#x0062f;&#x00645;&#x00627;&#x0062a; &#x00641;&#x0064a; &#x00631;&#x00641;&#x00639; &#x00645;&#x00633;&#x0062a;&#x00648;&#x00649; &#x00645;&#x00644;&#x00627;&#x00621;&#x00645;&#x00629; &#x00627;&#x00644;&#x00623;&#x0062f;&#x00648;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x00648;&#x00635;&#x00648;&#x00641;&#x00629; &#x00644;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00639;&#x00646;&#x0062f; &#x0062e;&#x00631;&#x00648;&#x0062c;&#x00647;&#x00645; &#x00645;&#x00646; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x00649; &#x00648;&#x0062a;&#x00641;&#x00627;&#x0062f;&#x0064a; &#x00639;&#x00648;&#x0062f;&#x0062a;&#x00647;&#x00645; &#x00645;&#x00646; &#x0062c;&#x0062f;&#x0064a;&#x0062f; &#x00644;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00634;&#x00641;&#x00627;&#x00621; &#x0062f;&#x00627;&#x0062e;&#x00644; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x00649;. </p></sec><sec><title>&#x00627;&#x00644;&#x00637;&#x00631;&#x0064a;&#x00642;&#x00629; </title><p>&#x00627;&#x00633;&#x0062a;&#x00639;&#x00646;&#x00627; &#x00628;&#x00645;&#x00631;&#x00636;&#x00649; &#x00645;&#x00635;&#x00627;&#x00628;&#x0064a;&#x00646; &#x00628;&#x00623;&#x00645;&#x00631;&#x00627;&#x00636; &#x0063a;&#x0064a;&#x00631; &#x00645;&#x00639;&#x0062f;&#x0064a;&#x00629; &#x0062f;&#x00627;&#x0062e;&#x00644; &#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x00649; &#x00644;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c; &#x00627;&#x00644;&#x0062a;&#x0062e;&#x00635;&#x00635;&#x0064a; &#x00641;&#x0064a; &#x00633;&#x00631;&#x0064a; &#x00644;&#x00627;&#x00646;&#x00643;&#x00627;&#x0060c; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00641;&#x0062a;&#x00631;&#x00629; &#x00628;&#x0064a;&#x00646; &#x00645;&#x00627;&#x00631;&#x00633;/&#x00622;&#x00630;&#x00627;&#x00631; &#x00648;&#x00633;&#x00628;&#x0062a;&#x00645;&#x00628;&#x00631;/&#x00623;&#x0064a;&#x00644;&#x00648;&#x00644; &#x00645;&#x00646; &#x00639;&#x00627;&#x00645; 2013&#x0060c; &#x00648;&#x00630;&#x00644;&#x00643; &#x00644;&#x00625;&#x0062c;&#x00631;&#x00627;&#x00621; &#x0062a;&#x0062c;&#x00631;&#x00628;&#x00629; &#x00633;&#x00631;&#x0064a;&#x00631;&#x0064a;&#x00629; &#x0063a;&#x0064a;&#x00631; &#x00645;&#x00639;&#x00634;&#x00627;&#x00629; &#x00645;&#x00636;&#x00628;&#x00637;&#x00629; &#x00628;&#x00627;&#x00644;&#x00634;&#x00648;&#x00627;&#x00647;&#x0062f;. &#x00648;&#x0062a;&#x00644;&#x00642;&#x0062a; &#x00627;&#x00644;&#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00627;&#x00644;&#x0062a;&#x0062c;&#x00631;&#x0064a;&#x00628;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00631;&#x00639;&#x00627;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00637;&#x00628;&#x0064a;&#x00629; &#x00648;&#x00627;&#x00644;&#x0062e;&#x0062f;&#x00645;&#x00629; &#x00627;&#x00644;&#x00635;&#x0064a;&#x0062f;&#x00644;&#x00627;&#x00646;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c;&#x0064a;&#x00629; &#x00628;&#x00627;&#x00644;&#x00637;&#x00631;&#x0064a;&#x00642;&#x00629; &#x00627;&#x00644;&#x00645;&#x00639;&#x0062a;&#x00627;&#x0062f;&#x00629;. &#x00648;&#x00623;&#x0062c;&#x00631;&#x00649; &#x00627;&#x00644;&#x00635;&#x0064a;&#x0062f;&#x00644;&#x0064a; &#x00627;&#x00644;&#x00645;&#x0062e;&#x0062a;&#x00635; &#x00628;&#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644; &#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c;&#x0064a; &#x00645;&#x00631;&#x00627;&#x0062c;&#x00639;&#x00627;&#x0062a; &#x00627;&#x00633;&#x0062a;&#x00628;&#x00627;&#x00642;&#x0064a;&#x00629; &#x00644;&#x00644;&#x00623;&#x0062f;&#x00648;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x00648;&#x00635;&#x00648;&#x00641;&#x00629;&#x0060c; &#x00648;&#x0062d;&#x0062f;&#x0062f; &#x00627;&#x00644;&#x00645;&#x00634;&#x00643;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x0062a;&#x00639;&#x00644;&#x00642;&#x00629; &#x00628;&#x00627;&#x00644;&#x0062f;&#x00648;&#x00627;&#x00621;&#x0060c; &#x00648;&#x00646;&#x00627;&#x00642;&#x00634; &#x00627;&#x00644;&#x0062a;&#x00648;&#x00635;&#x0064a;&#x00627;&#x0062a; &#x00645;&#x00639; &#x00643;&#x00644; &#x00645;&#x00646; &#x00641;&#x00631;&#x0064a;&#x00642; &#x00627;&#x00644;&#x00631;&#x00639;&#x00627;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00635;&#x0062d;&#x0064a;&#x00629; &#x00648;&#x00627;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649;. &#x00648;&#x00639;&#x00646;&#x0062f; &#x0062e;&#x00631;&#x00648;&#x0062c; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00645;&#x00646; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x00649;&#x0060c; &#x0062a;&#x00644;&#x00642;&#x00648;&#x00627; &#x00645;&#x00639;&#x00644;&#x00648;&#x00645;&#x00627;&#x0062a; &#x00634;&#x00641;&#x00647;&#x0064a;&#x00629; &#x00648;&#x00645;&#x00643;&#x0062a;&#x00648;&#x00628;&#x00629; &#x00628;&#x00634;&#x00623;&#x00646; &#x00627;&#x00644;&#x00623;&#x0062f;&#x00648;&#x0064a;&#x00629;. &#x00648;&#x0062d;&#x00635;&#x00644;&#x0062a; &#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00627;&#x00644;&#x00645;&#x00642;&#x00627;&#x00631;&#x00646;&#x00629; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00631;&#x00639;&#x00627;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00635;&#x0062d;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x00639;&#x0062a;&#x00627;&#x0062f;&#x00629;. &#x00648;&#x00627;&#x00633;&#x0062a;&#x00639;&#x00646;&#x00627; &#x00628;&#x00645;&#x00624;&#x00634;&#x00631; &#x00645;&#x00644;&#x00627;&#x00621;&#x00645;&#x00629; &#x00627;&#x00644;&#x0062f;&#x00648;&#x00627;&#x00621; &#x00644;&#x0062a;&#x00642;&#x0064a;&#x0064a;&#x00645; &#x00645;&#x0062f;&#x00649; &#x00643;&#x00641;&#x00627;&#x00621;&#x00629; &#x00648;&#x00635;&#x00641; &#x00627;&#x00644;&#x00623;&#x0062f;&#x00648;&#x0064a;&#x00629; &#x00644;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00639;&#x00646;&#x0062f; &#x0062e;&#x00631;&#x00648;&#x0062c;&#x00647;&#x00645; &#x00645;&#x00646; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x00649;. &#x00648;&#x00627;&#x00644;&#x0062a;&#x00642;&#x00649; &#x00623;&#x0062d;&#x0062f; &#x00627;&#x00644;&#x00635;&#x0064a;&#x00627;&#x0062f;&#x00644;&#x00629; &#x00645;&#x00639; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x0062e;&#x00644;&#x00627;&#x00644; &#x00641;&#x0062a;&#x00631;&#x00629; &#x00645;&#x0062a;&#x00627;&#x00628;&#x00639;&#x00629; &#x00627;&#x00633;&#x0062a;&#x00645;&#x00631;&#x0062a; &#x00644;&#x00633;&#x0062a;&#x00629; &#x00623;&#x00634;&#x00647;&#x00631;&#x0060c; &#x00644;&#x00644;&#x00648;&#x00642;&#x00648;&#x00641; &#x00639;&#x00644;&#x00649; &#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00639;&#x00648;&#x0062f;&#x00629; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00644;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00634;&#x00641;&#x00627;&#x00621; &#x00645;&#x00646; &#x0062c;&#x0062f;&#x0064a;&#x0062f; &#x0062f;&#x00627;&#x0062e;&#x00644; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x0064a;&#x00627;&#x0062a; &#x00644;&#x00623;&#x00633;&#x00628;&#x00627;&#x00628; &#x0062a;&#x0062a;&#x00639;&#x00644;&#x00642; &#x00628;&#x00627;&#x00644;&#x00623;&#x0062f;&#x00648;&#x0064a;&#x00629;. </p></sec><sec><title>&#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; </title><p>&#x0062a;&#x00648;&#x00641;&#x00631;&#x0062a; &#x00628;&#x0064a;&#x00627;&#x00646;&#x00627;&#x0062a; &#x00645;&#x00633;&#x0062a;&#x00645;&#x0062f;&#x00629; &#x00645;&#x00646; 361&#x000a0;&#x00645;&#x00631;&#x0064a;&#x00636;&#x0064b;&#x00627; &#x0064a;&#x00646;&#x0062f;&#x00631;&#x0062c;&#x00648;&#x00646; &#x00636;&#x00645;&#x00646; &#x00627;&#x00644;&#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00627;&#x00644;&#x0062a;&#x0062c;&#x00631;&#x0064a;&#x00628;&#x0064a;&#x00629; &#x00648;354&#x000a0;&#x00645;&#x00631;&#x0064a;&#x00636;&#x0064b;&#x00627; &#x0064a;&#x00646;&#x0062f;&#x00631;&#x0062c;&#x00648;&#x00646; &#x00636;&#x00645;&#x00646; &#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00627;&#x00644;&#x00645;&#x00642;&#x00627;&#x00631;&#x00646;&#x00629;&#x0060c; &#x00648;&#x0062e;&#x00636;&#x00639;&#x0062a; &#x0062a;&#x00644;&#x00643; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00627;&#x00646;&#x00627;&#x0062a; &#x00644;&#x00644;&#x0062a;&#x0062d;&#x00644;&#x0064a;&#x00644;. &#x00648;&#x00627;&#x00631;&#x0062a;&#x00641;&#x00639;&#x0062a; &#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x0062a;&#x00648;&#x00635;&#x00644; &#x00644;&#x0062d;&#x00644;&#x00648;&#x00644; &#x00644;&#x00644;&#x00645;&#x00634;&#x00643;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x0062a;&#x00639;&#x00644;&#x00642;&#x00629; &#x00628;&#x00627;&#x00644;&#x0062f;&#x00648;&#x00627;&#x00621; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00627;&#x00644;&#x0062a;&#x0062c;&#x00631;&#x0064a;&#x00628;&#x0064a;&#x00629; &#x00645;&#x00642;&#x00627;&#x00631;&#x00646;&#x00629;&#x0064b; &#x00628;&#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00627;&#x00644;&#x00645;&#x00642;&#x00627;&#x00631;&#x00646;&#x00629; <styled-content style-type="direction" style="direction:ltr;">(57.6&#x0200f;%</styled-content>&#x0061b; 592&#x0200f;/1027&#x0060c; &#x00641;&#x0064a; &#x00645;&#x00642;&#x00627;&#x00628;&#x00644; <styled-content style-type="direction" style="direction:ltr;">13.2&#x0200f;%</styled-content>&#x0061b; 161/1217&#x0061b; <italic>&#x00628;&#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644; </italic> &#x0003c; 0.001) &#x00648;&#x00643;&#x00627;&#x00646; &#x00627;&#x00644;&#x0062f;&#x00648;&#x00627;&#x00621; &#x00623;&#x00643;&#x0062b;&#x00631; &#x00645;&#x00644;&#x00627;&#x00621;&#x00645;&#x00629; &#x00644;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00627;&#x00644;&#x0062a;&#x0062c;&#x00631;&#x0064a;&#x00628;&#x0064a;&#x00629;&#x0060c; &#x00625;&#x00630; &#x00628;&#x00644;&#x0063a; &#x00645;&#x0062a;&#x00648;&#x00633;&#x00637; &#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; &#x00645;&#x00624;&#x00634;&#x00631; &#x00645;&#x00644;&#x00627;&#x00621;&#x00645;&#x00629; &#x00627;&#x00644;&#x0062f;&#x00648;&#x00627;&#x00621; &#x00644;&#x00644;&#x00645;&#x00631;&#x0064a;&#x00636; &#x00627;&#x00644;&#x00648;&#x00627;&#x0062d;&#x0062f; 1.25 &#x00641;&#x0064a; &#x00645;&#x00642;&#x00627;&#x00628;&#x00644; 4.3 &#x00644;&#x0062f;&#x00649; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00641;&#x0064a; &#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00627;&#x00644;&#x00645;&#x00642;&#x00627;&#x00631;&#x00646;&#x00629; (&#x00628;&#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644; &#x0003c; 0.001). &#x00648;&#x00627;&#x00646;&#x0062e;&#x00641;&#x00636;&#x0062a; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00627;&#x00644;&#x0062a;&#x0062c;&#x00631;&#x0064a;&#x00628;&#x0064a;&#x00629; &#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644;&#x0064a;&#x00629; &#x00639;&#x00648;&#x0062f;&#x00629; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00644;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00634;&#x00641;&#x00627;&#x00621; &#x00645;&#x00646; &#x0062c;&#x0062f;&#x0064a;&#x0062f; &#x0062f;&#x00627;&#x0062e;&#x00644; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x00649; &#x00628;&#x00633;&#x00628;&#x00628; &#x00645;&#x00634;&#x00643;&#x00644;&#x00627;&#x0062a; &#x0062a;&#x0062a;&#x00639;&#x00644;&#x00642; &#x00628;&#x00627;&#x00644;&#x00623;&#x0062f;&#x00648;&#x0064a;&#x00629; (&#x00641;&#x00643;&#x00627;&#x00646;&#x0062a; &#x00627;&#x00644;&#x00646;&#x00633;&#x00628;&#x00629; 44 &#x00645;&#x00646; &#x00628;&#x0064a;&#x00646; 311 &#x00641;&#x0064a; &#x00645;&#x00642;&#x00627;&#x00628;&#x00644; 93 &#x00645;&#x00646; &#x00628;&#x0064a;&#x00646; 311 &#x00641;&#x0064a; &#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00627;&#x00644;&#x00645;&#x00642;&#x00627;&#x00631;&#x00646;&#x00629;&#x0061b; <italic>&#x00628;&#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644; </italic> &#x0003c; 0.001). </p></sec><sec><title>&#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00646;&#x0062a;&#x00627;&#x0062c; </title><p>&#x00623;&#x0062f;&#x0062a; &#x0062e;&#x0062f;&#x00645;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00635;&#x0064a;&#x0062f;&#x00644;&#x00629; &#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x00642;&#x0062f;&#x00645;&#x00629; &#x00644;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00627;&#x00644;&#x00646;&#x00632;&#x00644;&#x00627;&#x00621; &#x00628;&#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x0064a;&#x00627;&#x0062a; &#x00625;&#x00644;&#x00649; &#x00627;&#x00631;&#x0062a;&#x00641;&#x00627;&#x00639; &#x00643;&#x00641;&#x00627;&#x00621;&#x00629; &#x00648;&#x00635;&#x00641; &#x00627;&#x00644;&#x0062f;&#x00648;&#x00627;&#x00621; &#x00627;&#x00644;&#x00645;&#x00644;&#x00627;&#x00626;&#x00645; &#x00644;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649;&#x0060c; &#x00645;&#x00645;&#x00627; &#x00623;&#x0062f;&#x00649; &#x00625;&#x00644;&#x00649; &#x0062a;&#x00642;&#x00644;&#x0064a;&#x00644; &#x00627;&#x00644;&#x00645;&#x00634;&#x00643;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x0062a;&#x00639;&#x00644;&#x00642;&#x00629; &#x00628;&#x00627;&#x00644;&#x00623;&#x0062f;&#x00648;&#x0064a;&#x00629; &#x00648;&#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00639;&#x00648;&#x0062f;&#x00629; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00627;&#x00644;&#x00645;&#x00635;&#x00627;&#x00628;&#x0064a;&#x00646; &#x00628;&#x00623;&#x00645;&#x00631;&#x00627;&#x00636; &#x0063a;&#x0064a;&#x00631; &#x00645;&#x00639;&#x0062f;&#x0064a;&#x00629; &#x00644;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00634;&#x00641;&#x00627;&#x00621; &#x00645;&#x00646; &#x0062c;&#x0062f;&#x0064a;&#x0062f; &#x0062f;&#x00627;&#x0062e;&#x00644; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x0064a;&#x00627;&#x0062a;. &#x00625;&#x00646; &#x0062a;&#x00642;&#x0062f;&#x0064a;&#x00645; &#x00647;&#x00630;&#x00627; &#x00627;&#x00644;&#x00646;&#x00648;&#x00639; &#x00645;&#x00646; &#x00627;&#x00644;&#x0062e;&#x0062f;&#x00645;&#x00627;&#x0062a; &#x00642;&#x0062f; &#x0064a;&#x00624;&#x0062f;&#x0064a; &#x00625;&#x00644;&#x00649; &#x0062a;&#x0062d;&#x00633;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00631;&#x00639;&#x00627;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00635;&#x0062d;&#x0064a;&#x00629; &#x00641;&#x0064a; &#x00633;&#x00631;&#x0064a; &#x00644;&#x00627;&#x00646;&#x00643;&#x00627; &#x00648;&#x00627;&#x00644;&#x00623;&#x00648;&#x00633;&#x00627;&#x00637; &#x00627;&#x00644;&#x00645;&#x00634;&#x00627;&#x00628;&#x00647;&#x00629; &#x00644;&#x00647;&#x00627;. <bold/></p></sec></trans-abstract><trans-abstract xml:lang="zh"><title>&#x06458;&#x08981;</title><sec><title>&#x076ee;&#x07684;</title><p>&#x065e8;&#x05728;&#x08bc4;&#x04f30;&#x057fa;&#x04e8e;&#x075c5;&#x0623f;&#x07684;&#x04e34;&#x05e8a;&#x0914d;&#x0836f;&#x0670d;&#x052a1;&#x089e3;&#x051b3;&#x04e0e;&#x0836f;&#x07269;&#x076f8;&#x05173;&#x07684;&#x095ee;&#x09898;&#x0540e;&#x0662f;&#x05426;&#x080fd;&#x0591f;&#x05728;&#x051fa;&#x09662;&#x065f6;&#x06539;&#x05584;&#x0836f;&#x07269;&#x06cbb;&#x07597;&#x07684;&#x09002;&#x05b9c;&#x06027;&#x05e76;&#x09884;&#x09632;&#x04e0e;&#x0836f;&#x07269;&#x076f8;&#x05173;&#x07684;&#x08fd4;&#x09662;&#x06cbb;&#x07597;&#x03002;</p></sec><sec><title>&#x065b9;&#x06cd5;</title><p>&#x06211;&#x04eec;&#x04e8e;&#x000a0;2013&#x000a0;&#x05e74;&#x000a0;3&#x000a0;&#x06708;&#x05230;&#x000a0;9&#x000a0;&#x06708;&#x0671f;&#x095f4;&#x05728;&#x065af;&#x091cc;&#x05170;&#x05361;&#x04e09;&#x07ea7;&#x062a4;&#x07406;&#x0533b;&#x09662;&#x062db;&#x052df;&#x04e86;&#x0975e;&#x04f20;&#x067d3;&#x06027;&#x075be;&#x075c5;&#x060a3;&#x08005;&#x0ff0c;&#x08fdb;&#x0884c;&#x04e86;&#x0975e;&#x0968f;&#x0673a;&#x05bf9;&#x07167;&#x04e34;&#x05e8a;&#x08bd5;&#x09a8c;&#x03002;&#x05e72;&#x09884;&#x07ec4;&#x063a5;&#x053d7;&#x04e86;&#x05e38;&#x089c4;&#x062a4;&#x07406;&#x0548c;&#x04e34;&#x05e8a;&#x0914d;&#x0836f;&#x0670d;&#x052a1;&#x03002;&#x05e72;&#x09884;&#x0836f;&#x05242;&#x05e08;&#x05f00;&#x05c55;&#x04e86;&#x05177;&#x06709;&#x0524d;&#x077bb;&#x06027;&#x07684;&#x0836f;&#x07269;&#x08bc4;&#x05ba1;&#x0ff0c;&#x0786e;&#x05b9a;&#x04e86;&#x04e0e;&#x0836f;&#x07269;&#x06709;&#x05173;&#x07684;&#x095ee;&#x09898;&#x0ff0c;&#x05e76;&#x04e0e;&#x0533b;&#x07597;&#x062a4;&#x07406;&#x056e2;&#x0961f;&#x0548c;&#x060a3;&#x08005;&#x08ba8;&#x08bba;&#x04e86;&#x05efa;&#x08bae;&#x03002;&#x051fa;&#x09662;&#x065f6;&#x0ff0c;&#x060a3;&#x08005;&#x06536;&#x05230;&#x04e86;&#x053e3;&#x05934;&#x0548c;&#x04e66;&#x09762;&#x07684;&#x0533b;&#x07597;&#x04fe1;&#x0606f;&#x03002;&#x05bf9;&#x07167;&#x07ec4;&#x063a5;&#x053d7;&#x04e86;&#x05e38;&#x089c4;&#x062a4;&#x07406;&#x03002;&#x06211;&#x04eec;&#x091c7;&#x07528;&#x04e86;&#x0836f;&#x07269;&#x09002;&#x05b9c;&#x06027;&#x06307;&#x06807;&#x06765;&#x08bc4;&#x04f30;&#x051fa;&#x09662;&#x065f6;&#x05f00;&#x0836f;&#x07684;&#x09002;&#x05b9c;&#x06027;&#x03002;&#x05728;&#x0516d;&#x04e2a;&#x06708;&#x07684;&#x0968f;&#x08bbf;&#x0671f;&#x05185;&#x0ff0c;&#x0836f;&#x05242;&#x05e08;&#x05bf9;&#x060a3;&#x08005;&#x08fdb;&#x0884c;&#x08bbf;&#x095ee;&#x04ee5;&#x0786e;&#x05b9a;&#x04e0e;&#x0836f;&#x07269;&#x076f8;&#x05173;&#x07684;&#x08fd4;&#x09662;&#x06cbb;&#x07597;&#x095ee;&#x09898;&#x03002;</p></sec><sec><title>&#x07ed3;&#x0679c;</title><p>&#x06765;&#x081ea;&#x05e72;&#x09884;&#x07ec4;&#x000a0;361&#x000a0;&#x04f4d;&#x060a3;&#x08005;&#x0548c;&#x05bf9;&#x07167;&#x07ec4;&#x000a0;354&#x000a0;&#x04f4d;&#x060a3;&#x08005;&#x07684;&#x06570;&#x0636e;&#x053ef;&#x04f9b;&#x05206;&#x06790;&#x03002;&#x04e0e;&#x05bf9;&#x07167;&#x07ec4;&#x076f8;&#x06bd4;&#x0ff0c;&#x05e72;&#x09884;&#x07ec4;&#x089e3;&#x051b3;&#x04e0e;&#x0836f;&#x07269;&#x06709;&#x05173;&#x095ee;&#x09898;&#x07684;&#x06982;&#x07387;&#x066f4;&#x09ad8;&#x0ff08;57.6%&#x0ff1b;592/1027&#x0ff0c;&#x05bf9;&#x06bd4;&#x000a0;13.2%&#x0ff1b;161/1217&#x0ff1b;P&#x000a0;&#x0003c;&#x000a0;0.001&#x0ff09;&#x0ff0c;&#x05e72;&#x09884;&#x07ec4;&#x07684;&#x0836f;&#x07269;&#x066f4;&#x09002;&#x05b9c;&#x03002;&#x060a3;&#x08005;&#x0836f;&#x07269;&#x09002;&#x05b9c;&#x06027;&#x06307;&#x06807;&#x07684;&#x05e73;&#x05747;&#x05206;&#x06570;&#x05206;&#x0522b;&#x04e3a;&#x000a0;1.25&#x000a0;&#x0548c;&#x000a0;4.3&#x0ff08;&#x05bf9;&#x07167;&#x07ec4;&#x0ff09;(P&#x000a0;&#x0003c;&#x000a0;0.001)&#x03002;&#x05e72;&#x09884;&#x07ec4;&#x060a3;&#x08005;&#x07531;&#x04e8e;&#x04e0e;&#x0836f;&#x07269;&#x076f8;&#x05173;&#x07684;&#x095ee;&#x09898;&#x0800c;&#x08fd4;&#x09662;&#x06cbb;&#x07597;&#x07684;&#x053ef;&#x080fd;&#x06027;&#x066f4;&#x04f4e;&#x0ff08;311&#x000a0;&#x04f4d;&#x060a3;&#x08005;&#x04e2d;&#x06709;&#x000a0;44&#x000a0;&#x04f4d;&#x0ff0c;&#x05bf9;&#x07167;&#x07ec4;&#x000a0;311&#x000a0;&#x04f4d;&#x060a3;&#x08005;&#x04e2d;&#x06709;&#x000a0;93&#x000a0;&#x04f4d;&#x0ff1b;P&#x000a0;&#x0003c;&#x000a0;0.001&#x0ff09;&#x03002;</p></sec><sec><title>&#x07ed3;&#x08bba;</title><p>&#x057fa;&#x04e8e;&#x075c5;&#x0623f;&#x07684;&#x04e34;&#x05e8a;&#x0914d;&#x0836f;&#x0670d;&#x052a1;&#x063d0;&#x05347;&#x04e86;&#x05904;&#x065b9;&#x09002;&#x05b9c;&#x06027;&#x0ff0c;&#x051cf;&#x05c11;&#x04e86;&#x0975e;&#x04f20;&#x067d3;&#x06027;&#x075be;&#x075c5;&#x060a3;&#x08005;&#x04e0e;&#x0836f;&#x07269;&#x076f8;&#x05173;&#x07684;&#x095ee;&#x09898;&#x0548c;&#x08fd4;&#x09662;&#x06cbb;&#x07597;&#x07387;&#x03002;&#x06b64;&#x07c7b;&#x0670d;&#x052a1;&#x07684;&#x05b9e;&#x065bd;&#x080fd;&#x0591f;&#x063d0;&#x05347;&#x065af;&#x091cc;&#x05170;&#x05361;&#x053ca;&#x07c7b;&#x04f3c;&#x05730;&#x0533a;&#x07684;&#x0533b;&#x07597;&#x062a4;&#x07406;&#x06c34;&#x05e73;&#x03002;</p></sec></trans-abstract><trans-abstract xml:lang="ru"><title>&#x00420;&#x00435;&#x00437;&#x0044e;&#x0043c;&#x00435;</title><sec><title>&#x00426;&#x00435;&#x0043b;&#x0044c;</title><p>&#x0041e;&#x00446;&#x00435;&#x0043d;&#x00438;&#x00442;&#x0044c;, &#x00441;&#x0043f;&#x0043e;&#x00441;&#x0043e;&#x00431;&#x00441;&#x00442;&#x00432;&#x0043e;&#x00432;&#x00430;&#x0043b;&#x00430; &#x0043b;&#x00438; &#x00434;&#x00435;&#x0044f;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0044c; &#x00431;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x00438;&#x00447;&#x0043d;&#x0043e;&#x00439; &#x0043a;&#x0043b;&#x00438;&#x0043d;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x0043e;&#x00439; &#x00430;&#x0043f;&#x00442;&#x00435;&#x00447;&#x0043d;&#x0043e;&#x00439; &#x00441;&#x0043b;&#x00443;&#x00436;&#x00431;&#x0044b; &#x0043f;&#x0043e; &#x00440;&#x00430;&#x00437;&#x00440;&#x00435;&#x00448;&#x00435;&#x0043d;&#x00438;&#x0044e; &#x0043f;&#x00440;&#x0043e;&#x00431;&#x0043b;&#x00435;&#x0043c;, &#x00441;&#x00432;&#x0044f;&#x00437;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00441; &#x0043b;&#x00435;&#x0043a;&#x00430;&#x00440;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x0043c;&#x00438; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x00430;&#x00440;&#x00430;&#x00442;&#x00430;&#x0043c;&#x00438;, &#x0043f;&#x0043e;&#x00432;&#x0044b;&#x00448;&#x00435;&#x0043d;&#x00438;&#x0044e; &#x00447;&#x00430;&#x00441;&#x00442;&#x0043e;&#x00442;&#x0044b; &#x00440;&#x00430;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x0043d;&#x00430;&#x00437;&#x0043d;&#x00430;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x0043b;&#x00435;&#x0043a;&#x00430;&#x00440;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x00430;&#x00440;&#x00430;&#x00442;&#x0043e;&#x00432; &#x0043f;&#x00440;&#x00438; &#x00432;&#x0044b;&#x0043f;&#x00438;&#x00441;&#x0043a;&#x00435; &#x00438; &#x0043f;&#x00440;&#x00435;&#x00434;&#x0043e;&#x00442;&#x00432;&#x00440;&#x00430;&#x00449;&#x00435;&#x0043d;&#x00438;&#x0044e; &#x0043f;&#x0043e;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0043d;&#x0043e;&#x00439; &#x00433;&#x0043e;&#x00441;&#x0043f;&#x00438;&#x00442;&#x00430;&#x0043b;&#x00438;&#x00437;&#x00430;&#x00446;&#x00438;&#x00438; &#x00432; &#x00441;&#x00432;&#x0044f;&#x00437;&#x00438; &#x00441; &#x0043f;&#x00440;&#x00438;&#x00435;&#x0043c;&#x0043e;&#x0043c; &#x0043d;&#x00430;&#x00437;&#x0043d;&#x00430;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043b;&#x00435;&#x0043a;&#x00430;&#x00440;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x00430;&#x00440;&#x00430;&#x00442;&#x0043e;&#x00432;.</p></sec><sec><title>&#x0041c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0044b;</title><p>&#x00412; &#x0043f;&#x00435;&#x00440;&#x00438;&#x0043e;&#x00434; &#x00441; &#x0043c;&#x00430;&#x00440;&#x00442;&#x00430; &#x0043f;&#x0043e; &#x00441;&#x00435;&#x0043d;&#x00442;&#x0044f;&#x00431;&#x00440;&#x0044c; 2013&#x000a0;&#x00433;&#x0043e;&#x00434;&#x00430; &#x00432; &#x00432;&#x0044b;&#x00441;&#x0043e;&#x0043a;&#x0043e;&#x00441;&#x0043f;&#x00435;&#x00446;&#x00438;&#x00430;&#x0043b;&#x00438;&#x00437;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0043e;&#x00439; &#x00431;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x00438;&#x00446;&#x00435; &#x00432; &#x00428;&#x00440;&#x00438;-&#x0041b;&#x00430;&#x0043d;&#x0043a;&#x00435; &#x0043c;&#x0044b; &#x0043f;&#x00440;&#x00438;&#x00433;&#x0043b;&#x00430;&#x00448;&#x00430;&#x0043b;&#x00438; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x0043e;&#x00432; &#x00441; &#x0043d;&#x00435;&#x00438;&#x0043d;&#x00444;&#x00435;&#x0043a;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x0043d;&#x0044b;&#x0043c;&#x00438; &#x00437;&#x00430;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;&#x0043c;&#x00438; &#x00434;&#x0043b;&#x0044f; &#x00443;&#x00447;&#x00430;&#x00441;&#x00442;&#x00438;&#x0044f; &#x00432; &#x0043d;&#x00435;&#x00440;&#x00430;&#x0043d;&#x00434;&#x0043e;&#x0043c;&#x00438;&#x00437;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0043e;&#x0043c; &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x00438;&#x00440;&#x00443;&#x00435;&#x0043c;&#x0043e;&#x0043c; &#x0043a;&#x0043b;&#x00438;&#x0043d;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x0043e;&#x0043c; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00438;. &#x0042d;&#x0043a;&#x00441;&#x0043f;&#x00435;&#x00440;&#x00438;&#x0043c;&#x00435;&#x0043d;&#x00442;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x00430;&#x0044f; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x00430; &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00438;&#x0043b;&#x00430; &#x00441;&#x00442;&#x00430;&#x0043d;&#x00434;&#x00430;&#x00440;&#x00442;&#x0043d;&#x0043e;&#x00435; &#x0043c;&#x00435;&#x00434;&#x00438;&#x00446;&#x00438;&#x0043d;&#x00441;&#x0043a;&#x0043e;&#x00435; &#x00438; &#x00430;&#x0043f;&#x00442;&#x00435;&#x00447;&#x0043d;&#x0043e;&#x00435; &#x0043e;&#x00431;&#x00441;&#x0043b;&#x00443;&#x00436;&#x00438;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00435;. &#x00424;&#x00430;&#x00440;&#x0043c;&#x00430;&#x00446;&#x00435;&#x00432;&#x00442; &#x0043f;&#x00440;&#x0043e;&#x00432;&#x00435;&#x0043b; &#x0043f;&#x00440;&#x0043e;&#x00441;&#x0043f;&#x00435;&#x0043a;&#x00442;&#x00438;&#x00432;&#x0043d;&#x0044b;&#x00439; &#x0043e;&#x00431;&#x00437;&#x0043e;&#x00440; &#x0043d;&#x00430;&#x00437;&#x0043d;&#x00430;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043b;&#x00435;&#x0043a;&#x00430;&#x00440;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x00430;&#x00440;&#x00430;&#x00442;&#x0043e;&#x00432;, &#x00432;&#x0044b;&#x0044f;&#x00432;&#x00438;&#x0043b; &#x00441;&#x00432;&#x0044f;&#x00437;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00441; &#x0043d;&#x00438;&#x0043c;&#x00438; &#x0043f;&#x00440;&#x0043e;&#x00431;&#x0043b;&#x00435;&#x0043c;&#x0044b; &#x00438; &#x0043e;&#x00431;&#x00441;&#x00443;&#x00434;&#x00438;&#x0043b; &#x00440;&#x00435;&#x0043a;&#x0043e;&#x0043c;&#x00435;&#x0043d;&#x00434;&#x00430;&#x00446;&#x00438;&#x00438; &#x00441;&#x0043e; &#x00441;&#x0043b;&#x00443;&#x00436;&#x00431;&#x0043e;&#x00439; &#x00437;&#x00434;&#x00440;&#x00430;&#x00432;&#x0043e;&#x0043e;&#x00445;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00438; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x00430;&#x0043c;&#x00438;. &#x0041f;&#x00440;&#x00438; &#x00432;&#x0044b;&#x0043f;&#x00438;&#x00441;&#x0043a;&#x00435; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x0044b; &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00438;&#x0043b;&#x00438; &#x00438;&#x0043d;&#x00444;&#x0043e;&#x00440;&#x0043c;&#x00430;&#x00446;&#x00438;&#x0044e; &#x0043e; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00438; &#x00432; &#x00443;&#x00441;&#x00442;&#x0043d;&#x0043e;&#x0043c; &#x00438; &#x0043f;&#x00438;&#x00441;&#x0044c;&#x0043c;&#x00435;&#x0043d;&#x0043d;&#x0043e;&#x0043c; &#x00432;&#x00438;&#x00434;&#x00435;. &#x0041a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x00430;&#x0044f; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x00430; &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00438;&#x0043b;&#x00430; &#x00442;&#x0043e;&#x0043b;&#x0044c;&#x0043a;&#x0043e; &#x00441;&#x00442;&#x00430;&#x0043d;&#x00434;&#x00430;&#x00440;&#x00442;&#x0043d;&#x0043e;&#x00435; &#x0043c;&#x00435;&#x00434;&#x00438;&#x00446;&#x00438;&#x0043d;&#x00441;&#x0043a;&#x0043e;&#x00435; &#x0043e;&#x00431;&#x00441;&#x0043b;&#x00443;&#x00436;&#x00438;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00435;. &#x0041c;&#x0044b; &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043b;&#x00438; &#x00438;&#x0043d;&#x00434;&#x00435;&#x0043a;&#x00441; &#x0043f;&#x00440;&#x00438;&#x00435;&#x0043c;&#x0043b;&#x00435;&#x0043c;&#x0043e;&#x00441;&#x00442;&#x00438; &#x0043b;&#x00435;&#x0043a;&#x00430;&#x00440;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x00430;&#x00440;&#x00430;&#x00442;&#x0043e;&#x00432; &#x00434;&#x0043b;&#x0044f; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x0043a;&#x00438; &#x00440;&#x00430;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00438;&#x00445; &#x0043d;&#x00430;&#x00437;&#x0043d;&#x00430;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x0043f;&#x00440;&#x00438; &#x00432;&#x0044b;&#x0043f;&#x00438;&#x00441;&#x0043a;&#x00435;. &#x00412; &#x00442;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00448;&#x00435;&#x00441;&#x00442;&#x00438;&#x0043c;&#x00435;&#x00441;&#x0044f;&#x00447;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x0043f;&#x00435;&#x00440;&#x00438;&#x0043e;&#x00434;&#x00430; &#x0043f;&#x0043e;&#x00441;&#x0043b;&#x00435;&#x00434;&#x00443;&#x0044e;&#x00449;&#x00435;&#x00433;&#x0043e; &#x0043d;&#x00430;&#x00431;&#x0043b;&#x0044e;&#x00434;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00444;&#x00430;&#x00440;&#x0043c;&#x00430;&#x00446;&#x00435;&#x00432;&#x00442; &#x0043f;&#x00440;&#x0043e;&#x00432;&#x0043e;&#x00434;&#x00438;&#x0043b; &#x0043e;&#x0043f;&#x00440;&#x0043e;&#x00441;&#x0044b; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x0043e;&#x00432; &#x00434;&#x0043b;&#x0044f; &#x00432;&#x0044b;&#x0044f;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00441;&#x0043b;&#x00443;&#x00447;&#x00430;&#x00435;&#x00432; &#x0043f;&#x0043e;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0043d;&#x0043e;&#x00439; &#x00433;&#x0043e;&#x00441;&#x0043f;&#x00438;&#x00442;&#x00430;&#x0043b;&#x00438;&#x00437;&#x00430;&#x00446;&#x00438;&#x00438;, &#x00441;&#x00432;&#x0044f;&#x00437;&#x00430;&#x0043d;&#x0043d;&#x0043e;&#x00439; &#x00441; &#x0043f;&#x00440;&#x00438;&#x00435;&#x0043c;&#x0043e;&#x0043c; &#x0043d;&#x00430;&#x00437;&#x0043d;&#x00430;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043b;&#x00435;&#x0043a;&#x00430;&#x00440;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x00430;&#x00440;&#x00430;&#x00442;&#x0043e;&#x00432;.</p></sec><sec><title>&#x00420;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b;</title><p>&#x00414;&#x0043b;&#x0044f; &#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437;&#x00430; &#x00431;&#x0044b;&#x0043b;&#x00438; &#x00434;&#x0043e;&#x00441;&#x00442;&#x00443;&#x0043f;&#x0043d;&#x0044b; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; 361&#x000a0;&#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x00430; &#x00432; &#x0044d;&#x0043a;&#x00441;&#x0043f;&#x00435;&#x00440;&#x00438;&#x0043c;&#x00435;&#x0043d;&#x00442;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00439; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x00435; &#x00438; 354&#x000a0;&#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x0043e;&#x00432; &#x00432; &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00439; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x00435;. &#x00420;&#x00430;&#x00437;&#x00440;&#x00435;&#x00448;&#x00435;&#x0043d;&#x00438;&#x00435; &#x0043f;&#x00440;&#x0043e;&#x00431;&#x0043b;&#x00435;&#x0043c;, &#x00441;&#x00432;&#x0044f;&#x00437;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00441; &#x0043f;&#x00440;&#x00438;&#x00435;&#x0043c;&#x0043e;&#x0043c; &#x0043d;&#x00430;&#x00437;&#x0043d;&#x00430;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043b;&#x00435;&#x0043a;&#x00430;&#x00440;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x00430;&#x00440;&#x00430;&#x00442;&#x0043e;&#x00432;, &#x00431;&#x0044b;&#x0043b;&#x0043e; &#x00432;&#x0044b;&#x00448;&#x00435; &#x00432; &#x0044d;&#x0043a;&#x00441;&#x0043f;&#x00435;&#x00440;&#x00438;&#x0043c;&#x00435;&#x0043d;&#x00442;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00439; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x00435; &#x0043f;&#x0043e; &#x00441;&#x00440;&#x00430;&#x00432;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044e; &#x00441; &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00439; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x0043e;&#x00439;&#x000a0;(57,6%, 592/1027, &#x0043f;&#x00440;&#x0043e;&#x00442;&#x00438;&#x00432; 13,2%, 161/1217, <italic>&#x00420;</italic>&#x000a0;&#x0003c;&#x000a0;0,001), &#x00438; &#x0043d;&#x00430;&#x00437;&#x0043d;&#x00430;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00435; &#x0043b;&#x00435;&#x0043a;&#x00430;&#x00440;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x00430;&#x00440;&#x00430;&#x00442;&#x0043e;&#x00432; &#x00431;&#x0044b;&#x0043b;&#x0043e; &#x00431;&#x0043e;&#x0043b;&#x00435;&#x00435; &#x00440;&#x00430;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x0043c; &#x00432; &#x0044d;&#x0043a;&#x00441;&#x0043f;&#x00435;&#x00440;&#x00438;&#x0043c;&#x00435;&#x0043d;&#x00442;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00439; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x00435;. &#x00421;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00435;&#x00435; &#x00437;&#x0043d;&#x00430;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00435; &#x0043f;&#x0043e;&#x0043a;&#x00430;&#x00437;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044f; &#x0043f;&#x00440;&#x00438;&#x00435;&#x0043c;&#x0043b;&#x00435;&#x0043c;&#x0043e;&#x00441;&#x00442;&#x00438; &#x0043b;&#x00435;&#x0043a;&#x00430;&#x00440;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00441;&#x00440;&#x00435;&#x00434;&#x00441;&#x00442;&#x00432;&#x00430; &#x00432; &#x00440;&#x00430;&#x00441;&#x00447;&#x00435;&#x00442;&#x00435; &#x0043d;&#x00430; &#x0043e;&#x00434;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x00430; &#x00441;&#x0043e;&#x00441;&#x00442;&#x00430;&#x00432;&#x00438;&#x0043b;&#x0043e; 1,25 &#x0043f;&#x00440;&#x0043e;&#x00442;&#x00438;&#x00432; 4,3 &#x00432; &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00439; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x00435;&#x000a0;(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0,001). &#x0041f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x0044b; &#x00432; &#x0044d;&#x0043a;&#x00441;&#x0043f;&#x00435;&#x00440;&#x00438;&#x0043c;&#x00435;&#x0043d;&#x00442;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00439; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x00435; &#x00438;&#x0043c;&#x00435;&#x0043b;&#x00438; &#x0043c;&#x00435;&#x0043d;&#x0044c;&#x00448;&#x00443;&#x0044e; &#x00432;&#x00435;&#x00440;&#x0043e;&#x0044f;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0044c; &#x0043f;&#x0043e;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0043d;&#x0043e;&#x00439; &#x00433;&#x0043e;&#x00441;&#x0043f;&#x00438;&#x00442;&#x00430;&#x0043b;&#x00438;&#x00437;&#x00430;&#x00446;&#x00438;&#x00438; &#x00438;&#x00437;-&#x00437;&#x00430; &#x0043f;&#x00440;&#x0043e;&#x00431;&#x0043b;&#x00435;&#x0043c;, &#x00441;&#x00432;&#x0044f;&#x00437;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00441; &#x0043f;&#x00440;&#x00438;&#x00435;&#x0043c;&#x0043e;&#x0043c; &#x0043d;&#x00430;&#x00437;&#x0043d;&#x00430;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043b;&#x00435;&#x0043a;&#x00430;&#x00440;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x00430;&#x00440;&#x00430;&#x00442;&#x0043e;&#x00432;&#x000a0;(44&#x000a0;&#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x00430; &#x00438;&#x00437;&#x000a0;311 &#x0043f;&#x00440;&#x0043e;&#x00442;&#x00438;&#x00432;&#x000a0;93 &#x00438;&#x00437;&#x000a0;311 &#x00432; &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00439; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x00435;, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0,001).</p></sec><sec><title>&#x00412;&#x0044b;&#x00432;&#x0043e;&#x00434;</title><p>&#x00414;&#x00435;&#x0044f;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0044c; &#x00431;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x00438;&#x00447;&#x0043d;&#x0043e;&#x00439; &#x0043a;&#x0043b;&#x00438;&#x0043d;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x0043e;&#x00439; &#x00430;&#x0043f;&#x00442;&#x00435;&#x00447;&#x0043d;&#x0043e;&#x00439; &#x00441;&#x0043b;&#x00443;&#x00436;&#x00431;&#x0044b; &#x0043f;&#x0043e;&#x00432;&#x0044b;&#x00441;&#x00438;&#x0043b;&#x00430; &#x00447;&#x00430;&#x00441;&#x00442;&#x0043e;&#x00442;&#x00443; &#x00440;&#x00430;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x0043d;&#x00430;&#x00437;&#x0043d;&#x00430;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x0043b;&#x00435;&#x0043a;&#x00430;&#x00440;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x00430;&#x00440;&#x00430;&#x00442;&#x0043e;&#x00432;, &#x00443;&#x0043c;&#x00435;&#x0043d;&#x0044c;&#x00448;&#x00438;&#x0043b;&#x00430; &#x00432;&#x0043e;&#x00437;&#x0043d;&#x00438;&#x0043a;&#x0043d;&#x0043e;&#x00432;&#x00435;&#x0043d;&#x00438;&#x00435; &#x0043f;&#x00440;&#x0043e;&#x00431;&#x0043b;&#x00435;&#x0043c;, &#x00441;&#x00432;&#x0044f;&#x00437;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00441; &#x0043f;&#x00440;&#x00438;&#x00435;&#x0043c;&#x0043e;&#x0043c; &#x0043d;&#x00430;&#x00437;&#x0043d;&#x00430;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043b;&#x00435;&#x0043a;&#x00430;&#x00440;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x00430;&#x00440;&#x00430;&#x00442;&#x0043e;&#x00432;, &#x00438; &#x00447;&#x00430;&#x00441;&#x00442;&#x0043e;&#x00442;&#x00443; &#x0043f;&#x0043e;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0043d;&#x0043e;&#x00439; &#x00433;&#x0043e;&#x00441;&#x0043f;&#x00438;&#x00442;&#x00430;&#x0043b;&#x00438;&#x00437;&#x00430;&#x00446;&#x00438;&#x00438; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x0043e;&#x00432; &#x00441; &#x0043d;&#x00435;&#x00438;&#x0043d;&#x00444;&#x00435;&#x0043a;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x0043d;&#x0044b;&#x0043c;&#x00438; &#x00437;&#x00430;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;&#x0043c;&#x00438;. &#x00412;&#x0043d;&#x00435;&#x00434;&#x00440;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00442;&#x00430;&#x0043a;&#x0043e;&#x00439; &#x00441;&#x0043b;&#x00443;&#x00436;&#x00431;&#x0044b; &#x0043c;&#x0043e;&#x00436;&#x00435;&#x00442; &#x00443;&#x0043b;&#x00443;&#x00447;&#x00448;&#x00438;&#x00442;&#x0044c; &#x00440;&#x00430;&#x00431;&#x0043e;&#x00442;&#x00443; &#x00441;&#x00438;&#x00441;&#x00442;&#x00435;&#x0043c;&#x0044b; &#x00437;&#x00434;&#x00440;&#x00430;&#x00432;&#x0043e;&#x0043e;&#x00445;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00432; &#x00428;&#x00440;&#x00438;-&#x0041b;&#x00430;&#x0043d;&#x0043a;&#x00435; &#x00438; &#x00432; &#x00430;&#x0043d;&#x00430;&#x0043b;&#x0043e;&#x00433;&#x00438;&#x00447;&#x0043d;&#x0044b;&#x00445; &#x00443;&#x00441;&#x0043b;&#x0043e;&#x00432;&#x00438;&#x0044f;&#x00445;.</p></sec></trans-abstract></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Noncommunicable diseases, such as cardiovascular diseases, cancer, chronic respiratory diseases and diabetes, are a major global health burden and are an increasing problem in low- and middle income countries.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="R2" ref-type="bibr"><sup>2</sup></xref> An important component of care for noncommunicable diseases is the quality use of medicines &#x02013; that is, selecting management options wisely, choosing suitable medicines if a medicine is considered necessary and using medicines safely and effectively. Failure of following this component may lead to drug-related problems, which are defined as &#x0201c;an event or circumstance involving drug therapy that actually or potentially interferes with desired health outcomes.&#x0201d;<xref rid="R3" ref-type="bibr"><sup>3</sup></xref> Such problems cause a large number of hospital admissions, many of which are avoidable.<xref rid="R4" ref-type="bibr"><sup>4</sup></xref></p><p>In high-income countries, clinical pharmacy services have been shown to improve quality use of medicines and reduce drug-related problems, hospital readmissions and health-care expenditures.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref><sup>&#x02013;</sup><xref rid="R8" ref-type="bibr"><sup>8</sup></xref> In low- and middle-income countries clinical pharmacy services are limited<xref rid="R9" ref-type="bibr"><sup>9</sup></xref><sup>,</sup><xref rid="R10" ref-type="bibr"><sup>10</sup></xref> and implementation of such services could faces various challenges, such as: (i)&#x000a0;lack of clinically qualified pharmacists;<xref rid="R11" ref-type="bibr"><sup>11</sup></xref> (ii)&#x000a0;poor pharmaceutical literacy among patients;<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> (iii)&#x000a0;under-utilization of research evidence due to underdeveloped health-care systems;<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> (iv)&#x000a0;restrictions in medicines regulatory capacity;<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> (v)&#x000a0;poor availability of essential medicines; and (vi)&#x000a0;limitations in accessing high quality medicines.<xref rid="R11" ref-type="bibr"><sup>11</sup></xref> Hence, findings from implementation of clinical pharmacy services in high-income countries cannot be generalizable to low- and middle-income countries.</p><p>In Sri Lankan public hospitals, there are no established ward-based clinical pharmacy services. Hospital pharmacists are engaged in procurement, storage and dispensing of medicine to patients. However, we have previously identified opportunities for clinical pharmacists to contribute to the quality use of medicines.<xref rid="R14" ref-type="bibr"><sup>14</sup></xref></p><p>This study evaluates the impact of a clinical pharmacy service in a Sri Lankan hospital. We assessed the resolution of inpatient drug-related problems, appropriateness of medications at discharge from hospital and drug-related hospital readmissions.</p></sec><sec sec-type="methods"><title>Method</title><sec><title>Study setting and design</title><p>We recruited patients from March to September 2013 for this non-randomized controlled clinical trial and made a follow-up from October 2013 to March 2014. The study took place in the university medical unit of the Colombo North Teaching Hospital, Sri Lanka, a 1421-bed tertiary-care hospital. This unit has a female and a male ward of 55 and 65 beds, respectively.</p><p>We recruited patients from the two medical wards for the intervention and control groups and we allocated wards instead of patients within wards to reduce the risk of group contamination. Between March and May 2013, the patients in the male ward received the intervention and the female patients were allocated to the control group. In June, none of the wards received the intervention. Between July and September 2013, the female patients received the intervention and male patients were allocated to the control group.</p></sec><sec><title>Study population</title><p>Eligible patients were those with chronic noncommunicable diseases who needed long-term follow-up at the medical clinic.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> Each day of the recruitment period, an independent medical officer approached eligible patients in each ward, as recorded chronologically in the admission register, informed them about the study and the voluntarily enrolment, and continued until five patients were recruited.</p><p>The patients also received an information leaflet in their native language. For patients agreeing to participate, they gave both a written and a verbal consent to be seen and followed-up by a pharmacist. We excluded patients if they had impaired conscious level with no carer to manage medicines, receiving long-term follow-up from another unit or had communication difficulties.</p><p>Using a 50% increase in patient knowledge after discharge as a surrogate for improved drug use, we calculated a sample size was 400 patients for each arm with the level of significance of 0.05 and statistical power of 90%.</p></sec><sec><title>Intervention</title><p>In addition to the standard care provided by physicians and nurses, the intervention group received clinical pharmacy services from a clinical intervention pharmacist, who recorded the current medication history of the patient on admission and reviewed the patients&#x02019; medication charts daily until discharge. To optimize the patient&#x02019;s medications, the intervention pharmacist reconciled the medication history taken at admission with the physician&#x02019;s admission medication history. Then at the time of transfer or discharge the prescribed medications were again reviewed. Discrepancies including deletions, additions or changes to the medication lists were noted. The pharmacist identified potential drug-related problems, recorded them on a data collection form and discussed the findings and possible resolutions with the health-care team at any time during the admission, hospital stay and at the time of discharge. For problems related to patient&#x02019;s knowledge about the medication, the pharmacist discussed the problem with the patient and gave recommendations. At discharge, the pharmacist provided the patients with verbal and written instructions, given in the local language, on the safe administration of their medicines and a medicine list. Providing this type of education at ward level was not current practice in the Sri Lankan hospital system.</p><p>Patients in the control group received only the standard care. An assessment pharmacist interviewed the control group patients to obtain their medication history at discharge and reviewed their pharmacotherapy retrospectively to identify drug-related problems. This pharmacist did not provide any feedback to attending medical teams and did not provide any education during hospital stay or at discharge.</p><p>The two pharmacists were not involved in recruitment of participants, but they were aware of the group allocation. Both pharmacists were local graduates with a Sri Lankan Bachelor of Pharmacy degree, who received training in clinical pharmacy as part of their undergraduate curriculum and were employed specifically for the study. At one occasion before the study and two occasions during the study, the pharmacists received local ward-based teaching from external senior Australian clinical pharmacists. This training included reviewing of medications and refining data collection and patient interview techniques. Once recruitment began, the senior clinical pharmacists located in Australia held weekly case-based tutorials and quality checked the medication reviews, via the telecommunication software Skype (Microsoft, Redmond, United States of America).<xref rid="R14" ref-type="bibr"><sup>14</sup></xref></p></sec><sec><title>Outcomes</title><p>Daily, the assessment pharmacist independently categorized the identified drug-related problems into one of six main classes &#x02013; adverse drug reaction, dosing error, wrong medicine or no medicine, drug use problem, interaction and other &#x02013; according to the Pharmaceutical Care Network Europe classification scheme version 5.01.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref> Every fortnight, in a Skype meeting, the two pharmacist, the two senior pharmacists and two local consultant physicians validated the categorization of selected drug-related problems (1167/2244). They reached consensus for any discrepancy by discussion and they recategorized drug-related problems when necessary.</p><p>The intervention pharmacist recorded the outcomes of the discussions with either health-care team or patients on a data collection form as either accepted &#x02013; that is, when the health-care team and patients accepted the recommendations &#x02013; or not accepted, that is, when the health-care team and patients did not agree with the recommendations. The assessment pharmacist received the data collection form after the patient was discharged and further classified accepted recommendations into either implemented or not implemented. Problems deemed not to be clinically important by the intervention pharmacist were not brought to the attention of the health-care team and were recorded as not discussed. Patients with resolved drug-related problems, either in the intervention group or control group, without the pharmacist&#x02019;s intervention were recorded as self-resolved. A more detailed description of the acceptance and attitudes of health-care staff members towards the introduction of clinical pharmacy service is reported elsewhere.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref></p><p>To evaluate the appropriateness of the prescribed medications at discharge, the assessment pharmacist used the validated tool: medication appropriateness index.<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> The index has judgment-based and criterion-based measures.<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> Summated index scores for a medication range from 0 to 18 with lower scores reflecting a more appropriate medication.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref> A patient score is the mean score of all the patients&#x02019; medications. We categorized those patients with a score of zero for all their medications as receiving appropriate medications.</p><p>After discharge, the assessment pharmacist interviewed the participants monthly, for a period of six months, to identify any drug-related hospital readmissions. The pharmacist used a pre-tested questionnaire to document readmission information. The pharmacist identified possible causes for drug-related readmissions as either adverse drug reactions, non-reconciled medicines on discharge prescription (resulting in medications being unintentionally continued, changed, stopped or restarted), therapeutic failure (including poor-compliance, poor patient knowledge on medications and reduced dose at discharge) or dispensing errors. We excluded readmissions related to medicines commenced after the patients&#x02019; discharge from the study.</p><p>We analysed the direct costs of medication related hospital readmissions. We used a tertiary-care hospital cost of 24.60 United States dollars (US$, conversion rate US$&#x000a0;1 to 130 Sri Lankan rupee in 2014) per bed and day<xref rid="R18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="R19" ref-type="bibr"><sup>19</sup></xref> and multiplied that cost by the estimated number of prevented readmissions in the intervention group and by the observed average duration of a hospital readmission stay. Finally, we extrapolated the estimated cost to a full year.</p></sec><sec><title>Data Analysis</title><p>We entered the data into SPSS, Version 21 (IBM, Chicago, USA). An independent second investigator cleaned and audited the entered data. To identify differences between the groups, we used <italic>&#x003c7;2</italic> test for categorical data and independent sample <italic>t</italic>-test for parametric continuous data. We considered <italic>P</italic>-values less than 0.05 to be statistically significant.</p></sec><sec><title>Ethics</title><p>We received ethical approval from the Ethics Review Committee of the Faculty of Medicine, University of Kelaniya, Sri Lanka (Ref. No. P 12/01/2012). The trial was registered under Sri Lanka Clinical Trials Registry (Reg No: SLCTR/2013/029).</p><p>We obtained written informed consent, in their own language, from each patient or their relative if the patients were not competent to give consent. The purpose of the trial, the voluntary nature of the consent and the ability of participants to withhold the consent without any effect on their medical care were clearly explained before obtaining consent.</p></sec></sec><sec sec-type="results"><title>Results</title><p>We recruited 800 patients, of them data from 361 patients in the intervention group and 354 patients in the control group were available for analysis of resolution of drug-related problems and appropriateness of medication at discharge. For the assessment of drug-related hospital readmissions, the assessment pharmacist reached and interviewed 334 patients in the intervention group and 311 patients in the control group (<xref ref-type="fig" rid="F1">Fig.&#x000a0;1</xref>).</p><fig id="F1" fig-type="figure" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Flowchart of participants included in the non-randomized controlled clinical trial on ward-based pharmacist and hospital readmission, Sri Lanka, 2013&#x02013;2014</p></caption><graphic xlink:href="BLT.17.198366-F1"/></fig><p>There were no significant differences between the two groups in age, gender, highest level of education, underlying noncommunicable disease diagnosis and number of medications (<xref ref-type="table" rid="T1">Table&#x000a0;1</xref>).</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Description of patients participating in non-randomized controlled clinical trial on ward-based pharmacist and hospital readmission, Sri Lanka, 2013&#x02013;2014</title></caption><table frame="hsides" rules="groups"><col width="270" span="1"/><col width="77" span="1"/><col width="77" span="1"/><col width="87" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Variables</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Control (<italic>n</italic>&#x02009;=&#x02009;354)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Intervention (<italic>n</italic>&#x02009;=&#x02009;361)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Age in years, mean (SD)</bold></td><td valign="top" align="center" rowspan="1" colspan="1">58.3 (14.8)</td><td valign="top" align="center" rowspan="1" colspan="1">56.9&#x02009;(15.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0.270</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Gender, no. (%)</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.478</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Male</td><td valign="top" align="center" rowspan="1" colspan="1">171 (48.3)</td><td valign="top" align="center" rowspan="1" colspan="1">184 (51.0)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Female</td><td valign="top" align="center" rowspan="1" colspan="1">183 (51.7)</td><td valign="top" align="center" rowspan="1" colspan="1">177 (49.0)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Education, no. (%)</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.128</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No schooling</td><td valign="top" align="center" rowspan="1" colspan="1">6 (1.7)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (1.9)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Grade 1&#x02013;5</td><td valign="top" align="center" rowspan="1" colspan="1">46 (13.0)</td><td valign="top" align="center" rowspan="1" colspan="1">39 (10.8)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Grade 6&#x02013;11</td><td valign="top" align="center" rowspan="1" colspan="1">119(33.6)</td><td valign="top" align="center" rowspan="1" colspan="1">114 (31.6)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Completed ordinary level examination</td><td valign="top" align="center" rowspan="1" colspan="1">107 (30.2)</td><td valign="top" align="center" rowspan="1" colspan="1">104 (28.8)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Completed advanced level examination</td><td valign="top" align="center" rowspan="1" colspan="1">61 (17.2)</td><td valign="top" align="center" rowspan="1" colspan="1">78 (21.6)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">University degree or higher</td><td valign="top" align="center" rowspan="1" colspan="1">14 (4.0)</td><td valign="top" align="center" rowspan="1" colspan="1">19 (5.3)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Other</td><td valign="top" align="center" rowspan="1" colspan="1">1 (0.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0.0)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Diagnosis, no (%)</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.156</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cardiovascular diseases</td><td valign="top" align="center" rowspan="1" colspan="1">169 (47.8)</td><td valign="top" align="center" rowspan="1" colspan="1">163 (45.2)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Endocrine diseases</td><td valign="top" align="center" rowspan="1" colspan="1">78(22.1)</td><td valign="top" align="center" rowspan="1" colspan="1">81(22.3)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chronic respiratory diseases</td><td valign="top" align="center" rowspan="1" colspan="1">33 (9.4)</td><td valign="top" align="center" rowspan="1" colspan="1">27 (7.6)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Gastrointestinal diseases</td><td valign="top" align="center" rowspan="1" colspan="1">20 (5.6)</td><td valign="top" align="center" rowspan="1" colspan="1">30 (8.4)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>No. of medications per patient, mean (SD)</bold></td><td valign="top" align="center" rowspan="1" colspan="1">6.1&#x02009;(3.0)</td><td valign="top" align="center" rowspan="1" colspan="1">6.2&#x02009;(3.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.578</td></tr></tbody></table><table-wrap-foot><p>SD: standard deviation.</p></table-wrap-foot></table-wrap><sec><title>Drug-related problems</title><p>The two pharmacists identified in total 1027 drug-related problems in the intervention group, which was similar to the 1217 problems identified in the control group. Resolution of drug-related problem was significantly higher in the intervention group than the control group; 57.6% (592/1027) versus 13.2% (161/1217; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; <xref ref-type="table" rid="T2">Table&#x000a0;2</xref>).</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Drug-related problems, medication appropriateness and hospital readmissions for patients with noncommunicable diseases, a non-randomized controlled trial on ward-based pharmacist, Sri Lanka, 2013&#x02013;2014</title></caption><table frame="hsides" rules="groups"><col width="333" span="1"/><col width="85" span="1"/><col width="113" span="1"/><col width="63" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Outcome</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Control group (354 patients)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Intervention group (361 patients)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>No. of drug-related problems</bold></td><td valign="top" align="center" rowspan="1" colspan="1">1217</td><td valign="top" align="center" rowspan="1" colspan="1">1027</td><td valign="top" align="center" rowspan="1" colspan="1">0.25</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>No. of resolved drug-related problems (%)</bold></td><td valign="top" align="center" rowspan="1" colspan="1">161 (13.2)</td><td valign="top" align="center" rowspan="1" colspan="1">592 (57.6)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>MAI at discharge<sup>a</sup></bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mean score per patient (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">4.3 (6.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1.3 (2.9)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mean score per medication</td><td valign="top" align="center" rowspan="1" colspan="1">0.7 (2.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.2 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1"> &#x0003c;&#x02009;0.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No. of patients with appropriate medicines at discharge,<sup>b</sup> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">105 (29.7)</td><td valign="top" align="center" rowspan="1" colspan="1">202 (56.0)</td><td valign="top" align="center" rowspan="1" colspan="1"> &#x0003c;&#x02009;0.001</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Drug-related hospital readmissions</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No. of patients reached and interviewed<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">311</td><td valign="top" align="center" rowspan="1" colspan="1">334</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No. of drug-related hospital readmissions (%)</td><td valign="top" align="center" rowspan="1" colspan="1">93 (29.9)</td><td valign="top" align="center" rowspan="1" colspan="1">44 (13.2)</td><td valign="top" align="center" rowspan="1" colspan="1"> &#x0003c;&#x02009;0.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No. of readmissions due to non-compliance to medicines (%)</td><td valign="top" align="center" rowspan="1" colspan="1">49 (52.7)</td><td valign="top" align="center" rowspan="1" colspan="1">15 (34.1)</td><td valign="top" align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No. of readmissions due to non-reconciliation of medications (%)</td><td valign="top" align="center" rowspan="1" colspan="1">17 (18.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (2.3)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr></tbody></table><table-wrap-foot><p>CI: confidence interval; MAI: medication appropriateness index; SD: standard deviation.</p><p><sup>a</sup> MAI scores range from 0&#x02013;18 with lowest scores most appropriate.<xref rid="R19" ref-type="bibr"><sup>19</sup></xref></p><p><sup>b</sup> We categorized those patients with a score of zero for all their medications as receiving appropriate medications.</p><p><sup>c</sup> After hospital discharge, the assessment pharmacist interviewed all subjects monthly, for a period of six months, to identify any drug-related hospital readmissions.</p></table-wrap-foot></table-wrap><p>The intervention pharmacist prospectively identified 723 drug-related problems in the intervention group. Of these, depending on the nature of the problem, the pharmacist discussed 274 (37.9%) drug-related problems with the health-care team and 449 (62.1%) problems with the patients. The health-care team accepted the pharmacist&#x02019;s recommendations for 227 (82.8%) drug-related problems, however only 202 recommendations were implemented (<xref ref-type="table" rid="T3">Table&#x000a0;3</xref>). <xref ref-type="table" rid="T4">Table&#x000a0;4</xref> summarizes the number and type of drug-related problems per therapeutic class and <xref ref-type="boxed-text" rid="B1">Box&#x000a0;1</xref> presents some example of advices the pharmacist gave to patients.</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Outcomes of drug-related problems Sri Lanka, 2013&#x02013;2014</title></caption><table frame="hsides" rules="groups"><col width="326" span="1"/><col width="77" span="1"/><col width="70" span="1"/><col width="77" span="1"/><col width="77" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Group</th><th colspan="4" valign="top" align="center" scope="colgroup" rowspan="1">No. (%)<hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Self-resolved</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Resolved<sup>a</sup>
</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Not resolved</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Loss to follow-up<sup>b</sup></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Control group (1217 drug-related problems)</bold></td><td valign="top" align="center" rowspan="1" colspan="1">161 (13.2)</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td><td valign="top" align="center" rowspan="1" colspan="1">1041 (85.5)</td><td valign="top" align="center" rowspan="1" colspan="1">15 (1.2)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Intervention group (1027 drug-related problems)</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Prospective identification<sup>c</sup></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;Health-care team (274 drug-related problems)<sup>d</sup></td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td><td valign="top" align="center" rowspan="1" colspan="1">202 (73.7)</td><td valign="top" align="center" rowspan="1" colspan="1">72 (26.3)<sup>e</sup></td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;Patient (449 drug-related problems)<sup>f</sup></td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td><td valign="top" align="center" rowspan="1" colspan="1">360 (80.2)</td><td valign="top" align="center" rowspan="1" colspan="1">65 (14.5)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (5.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Retrospective identification (304 drug-related problems)<sup>g</sup></td><td valign="top" align="center" rowspan="1" colspan="1">30 (9.9)</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td><td valign="top" align="center" rowspan="1" colspan="1">274 (90.1)</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr></tbody></table><table-wrap-foot><p>N/A: not applicable.</p><p><sup>a</sup> The intervention that pharmacist suggested was accepted and implemented.</p><p><sup>b</sup> Due to death or transfer.</p><p><sup>c</sup> By clinical intervention pharmacist.</p><p><sup>d</sup> Intervention pharmacist discussed the problems with the team and gave recommendations about solution to the problems.</p><p><sup>e</sup> Of the 72 problems that were not resolved, the health-care team accepted but did not implement the pharmacist&#x02019;s recommendations for 25 problems and 47 recommendations were not accepted.</p><p><sup>e</sup> Intervention pharmacist discussed the problems with the patients and gave recommendations. </p><p><sup>f</sup> By assessment pharmacist.</p></table-wrap-foot></table-wrap><table-wrap id="T4" orientation="portrait" position="float"><label>Table 4</label><caption><title>Types of drug-related problems, per therapeutic class, identified during the non-randomized controlled clinical trial on ward-based pharmacist and hospital readmission, Sri Lanka, 2013&#x02013;2014</title></caption><table frame="hsides" rules="groups"><col width="117" span="1"/><col width="221" span="1"/><col width="63" span="1"/><col width="56" span="1"/><col width="64" span="1"/><col width="63" span="1"/><col width="77" span="1"/><col width="51" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Therapeutic class of medicine</th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">Most commonly prescribed medicines</th><th colspan="6" valign="top" align="center" scope="colgroup" rowspan="1">Type of drug-related problem, no.<hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Adverse drug reaction</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Dosing error</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Wrong medicine or no medicine</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Drug use problem</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Interaction</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Other<sup>a</sup></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Medicine used for allergy or anaphylaxis</td><td valign="top" align="left" rowspan="1" colspan="1">Chlorpheniramine, flunarizine, loratadine, cinnarizine, fexofenadine, cetirizine</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Analgesics</td><td valign="top" align="left" rowspan="1" colspan="1">Paracetamol, diclofenac, tramadol</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Anti-infectives</td><td valign="top" align="left" rowspan="1" colspan="1">Co-amoxiclav, amoxicillin, cloxacillin, penicillin, cefuroxime, cefixime, clarithromycin, ciprofloxacin, norfloxacin, metronidazole</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">56</td><td valign="top" align="center" rowspan="1" colspan="1">76</td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cardiovascular medicines</td><td valign="top" align="left" rowspan="1" colspan="1">Atorvastatin, aspirin, losartan, isosorbide mononitrate, furosemide, clopidogrel, glyceryl trinitrate, enalapril, spironolactone, atenolol</td><td valign="top" align="center" rowspan="1" colspan="1">163</td><td valign="top" align="center" rowspan="1" colspan="1">26</td><td valign="top" align="center" rowspan="1" colspan="1">378</td><td valign="top" align="center" rowspan="1" colspan="1">88</td><td valign="top" align="center" rowspan="1" colspan="1">33</td><td valign="top" align="center" rowspan="1" colspan="1">131</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Endocrine medicines</td><td valign="top" align="left" rowspan="1" colspan="1">Metformin, tolbutamide, insulin, gliclazide, thyroxine, glibenclamide, alendronate sodium</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">13</td><td valign="top" align="center" rowspan="1" colspan="1">76</td><td valign="top" align="center" rowspan="1" colspan="1">73</td><td valign="top" align="center" rowspan="1" colspan="1">34</td><td valign="top" align="center" rowspan="1" colspan="1">14</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ear and ophthalmic medicines</td><td valign="top" align="left" rowspan="1" colspan="1">Betahistine, prednisolone eye drops, xylometazoline, timolol</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Gastrointestinal medicines</td><td valign="top" align="left" rowspan="1" colspan="1">Omeprazole, pantoprazole, esomeprazole, famotidine, lactulose, domperidone, ursodiol, <italic>Helicobacter pylori</italic> kit<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">102</td><td valign="top" align="center" rowspan="1" colspan="1">125</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">53</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Genitourinary medicines</td><td valign="top" align="left" rowspan="1" colspan="1">Tamsulosin, finasteride, sildenafil</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Immunomodulators and antineoplastics</td><td valign="top" align="left" rowspan="1" colspan="1">Azathioprine, methotrexate, betamethasone, dexamethasone, prednisolone, sulfasalazine</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Neurological medicines</td><td valign="top" align="left" rowspan="1" colspan="1">Phenytoin, sodium valproate, carbamazepine, carbidopa/levodopa, benzhexol, gabapentin, pregabalin</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">24</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">1</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Psychotropic medicines</td><td valign="top" align="left" rowspan="1" colspan="1">Amitriptyline, fluoxetine, alprazolam, clonazepam, phenobarbital, risperidone, diazepam, olanzapine, zolpidem, aripiprazole</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Respiratory medicines</td><td valign="top" align="left" rowspan="1" colspan="1">Salbutamol, beclomethasone, fluticasone/salmeterol, theophylline, budesonide/formoterol</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">22</td><td valign="top" align="center" rowspan="1" colspan="1">97</td><td valign="top" align="center" rowspan="1" colspan="1">13</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">1</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Vitamins and mineral supplements</td><td valign="top" align="left" rowspan="1" colspan="1">Folic acid, calcium t, vitamin&#x000a0;B, iron, multivitamins, vitamin&#x000a0;C, 1-alfa-cholecalciferol, vitamin&#x000a0;A+D</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">70</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup> Treatment failure, patient dissatisfied with therapy despite taking drug(s) correctly, poor understanding of disease, unclear complaints.</p><p><sup>b</sup> Patient receives triple therapies for 10&#x02013;14 days. The treatment regimens are: (i)&#x000a0;omeprazole, amoxicillin and clarithromycin for 10 days; (ii)&#x000a0;bismuth subsalicylate, metronidazole, and tetracycline for 14 days; and (iii)&#x000a0;lansoprazole, amoxicillin, and clarithromycin, which has been approved for either 10 days or 14 days of treatment.</p><p>Note: We could not classify 402 drug-related problems into a single therapeutic class.</p></table-wrap-foot></table-wrap><boxed-text id="B1" position="float" orientation="portrait"><label>Box&#x000a0;1</label><caption><title>Example of recommendations the ward-based pharmacist gave to patients with drug-related problems, Sri Lanka, 2013&#x02013;2014</title></caption><sec><title>Adverse drug reaction</title><p>Pharmacist provided education on how to recognize or minimize adverse drug reactions. Examples include recognizing hypoglycaemic symptoms with diabetic medications or advice to minimize the risk of bleeding with warfarin.</p></sec><sec><title>Dosing error</title><p>Pharmacist provided education on correct use of dosage measuring device or identifying continued use of previous dose that had been changed at earlier visit.</p></sec><sec><title>Wrong medicine or no medicine</title><p>Pharmacist identified that patient had not received any medicine for the indications or had received prescriptions of the same medication from multiple prescribers, for example diuretics and antibiotics.</p></sec><sec><title>Drug use problem</title><p>Pharmacist educated patient on appropriate use of medication, for example, distinguishing between symptom relief and prophylaxis inhalers in asthma or nitrate-free intervals in ischaemic heart disease. Pharmacist gave information on correct storage of medications, such as insulin and glyceryl trinitrate.</p></sec><sec><title>Drug interaction</title><p>Pharmacist educated patient about food-medicine interactions and when to take medicines in relation to food, such as warfarin or nonsteroidal anti-inflammatory drugs.</p></sec><sec><title>Other</title><p>Pharmacist identified patients with high risk of poor compliance or poor knowledge about prescribed medicines.</p></sec></boxed-text></sec><sec><title>Medication appropriateness index</title><p>The mean index score per patient at discharge was significantly lower in the intervention group than the control group (1.3 versus 4.3; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), resulting in a significantly higher proportion of patients who were discharged with appropriate medication (202/361 in the intervention group versus 105/354 in control group; <xref ref-type="table" rid="T2">Table&#x000a0;2</xref>).</p></sec><sec><title>Hospital readmissions</title><p>Of the 645 patients interviewed, 137 reported drug-related readmissions during the follow-up period. In the control group, 29.9% (93/311) of patients had at least one drug-related hospital readmission, which was significantly higher than for the patients in the intervention group (13.2%; 44/334; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; <xref ref-type="table" rid="T2">Table&#x000a0;2</xref>).</p><sec><title>Estimated savings</title><p>Average length of hospital stay for a drug-related readmission was two days. The study pharmacist contributed to the care of eight patients per day and hence they could attend 2500 patients annually. The difference of drug-related hospital readmissions associated with the pharmacist&#x02019;s intervention was 16.7% (95% confidence interval, CI: 10.5&#x02013;23.0), resulting in an estimated 108 adverted readmissions during the study period. This reduction would save approximately 835 bed days per year. Estimated direct savings due to reduced readmissions is US$&#x000a0;20&#x02009;541 (95% CI: 10&#x02009;340&#x02013;24&#x02009;200), which is greater than an annual pharmacist salary of US$&#x000a0;2880.<xref rid="R20" ref-type="bibr"><sup>20</sup></xref></p></sec></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>In this study, a ward-based pharmacist intervention was associated with a significant reduction in drug-related hospital readmissions. This reduction was consistent with the observed improvement in resolving drug-related problems during hospital stay and the discharge medication appropriateness index. These improvements are consistent with findings from high-income countries where clinical pharmacy services are well established.<xref rid="R6" ref-type="bibr"><sup>6</sup></xref><sup>,</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="R22" ref-type="bibr"><sup>22</sup></xref> In Sweden, the addition of a clinical pharmacist to the health-care system undertaking similar interventions as in our study reduced hospital readmissions and led to a saving of US$&#x000a0;1&#x02009;000&#x02009;000 per year in health-care costs.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref> Clinical pharmacists in Australia providing timely communication of the discharge medication plan to patients&#x02019; primary-care physicians and community pharmacists led to significantly reduced unplanned hospital readmissions.<xref rid="R6" ref-type="bibr"><sup>6</sup></xref> A systematic review on economic evaluations of clinical pharmacy services demonstrated cost&#x02013;effectiveness, however, the review lacked studies from Asia or Africa.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref> In our study, a simple cost analysis, which did not include estimates of societal costs, supports the introduction of clinical pharmacy service in Sri Lanka.</p><p>Lack of provision of patient information on safe medication administration at discharge is a common problem within the Sri Lankan hospital system.<xref rid="R23" ref-type="bibr"><sup>23</sup></xref> This intervention directly addressed this gap as an intervention pharmacist provided both verbal and written medication information to patients. This communication combined with a higher proportion of appropriate discharge prescriptions were likely to have contributed to reducing drug-related hospital readmissions in the intervention group.</p><p>In this study, the proportion of the drug-related problems that were resolved was significantly higher in the intervention group than the control group, which also has been shown in other studies.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref><sup>,</sup><xref rid="R23" ref-type="bibr"><sup>23</sup></xref><sup>,</sup><xref rid="R24" ref-type="bibr"><sup>24</sup></xref> While one can assume that resolution of drug-related problems during the inpatient stay may have improved individual patient outcomes, our study was not powered to demonstrate this outcome.</p><p>Medical student courses in Sri Lanka teach core elements of quality use of medicines principles, but few institutional resources exist to support quality use of medicines, such as having a clinical pharmacist. This study was not powered to demonstrate improved prescribing behaviour of individual physicians and their ability to anticipate and avoid frequent adverse events. These would be interesting questions for future research.</p><p>In Sri Lanka, public hospital pharmacists only dispense medicines to inpatients. This study provides evidence to support the addition of a ward-based clinical pharmacy services for noncommunicable diseases in hospitals. We have previously demonstrated a high acceptability of the pharmacist&#x02019;s recommendations by the health-care team, especially the physicians.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> This supports the feasibility of introducing clinical pharmacists into ward-based health-care teams in Sri Lankan public hospitals. The acceptability is comparable to results from studies conducted in countries where clinical pharmacy is well developed and established.<xref rid="R21" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="R24" ref-type="bibr"><sup>24</sup></xref></p><p>Given the increasing burden of noncommunicable diseases in low- and middle-income countries,<xref rid="R2" ref-type="bibr"><sup>2</sup></xref> health systems need to adjust as part of the overall noncommunicable diseases strategy. Furthermore, our findings demonstrate a strategic approach to addressing the World Health Organization&#x02019;s 3rd Global Patient Safety Challenge of reducing harm from medicines in high risk situations, addressing appropriateness of medicines and reducing risks at transitions of care.<xref rid="R25" ref-type="bibr"><sup>25</sup></xref></p><p>The Sri Lankan government has invested in clinical pharmacy training as a component of a Bachelor of Pharmacy. The government has now the capacity and an opportunity to improve health outcomes by investing in ward-based clinical pharmacy services in public hospitals.<xref rid="R26" ref-type="bibr"><sup>26</sup></xref> Currently, up to 100 students are graduating from five state universities annually, however, neither health policy nor funded positions has been established for the implementation of clinical pharmacy services in the country. The findings of this study provide evidence to policy-makers to support the establishment of clinical services in Sri Lanka and in other low- and middle-income countries. Our results are widely applicable especially to settings where the clinical pharmacy service is not well established.</p><p>The study has some limitations. First, the study population was patients with noncommunicable diseases, thus the results might not be generalizable to other patient groups. While a limited analysis demonstrated cost savings, a more extensive cost analysis in this patient group and other groups should be done to explore the most cost&#x02013;effective way of using clinical pharmacists in Sri Lanka. Second, the results are likely to be only generalizable to tertiary-care hospitals with strong support from lead medical clinicians. This level of support may not be available in smaller hospitals. Nevertheless, tertiary hospitals can provide training for pharmacists as health professionals in a multidisciplinary care team. These trained clinical pharmacists. could then work in lower level hospitals. Third, doctors being aware of the study may have improved their prescribing behaviour even for the control group, the so-called Hawthorne effect.<xref rid="R27" ref-type="bibr"><sup>27</sup></xref> However, any improvement in quality use of medicines in the control group, as a result of improved prescribing, would likely reduce the difference between control and intervention outcomes, leading to underestimation of the effect. Fourth, the assessment pharmacist was not blinded to patient group allocation. However, this was not likely to produce significant bias in the objective outcomes of readmission, measurement of medication appropriateness and drug-related problems, which were assessed using established validated tools. Fifth, our intervention pharmacists did receive mentoring via teleconference from Australian clinical pharmacists who were part of the investigation team and the Collaboration of Australian and Sri Lankans for Pharmacy Practice Education and Research. Absence of such support may affect the generalisability of our study. Similar collaborations between pharmacy workforce in low-and middle-income countries and high-income countries would be a strategic component of the initial stages of a scale-up of clinical pharmacy services. Finally, the study used self-reported responses to assess patients&#x02019; drug-related hospital readmissions. Self-reporting is a less reliable method than more objective measures. However, the magnitude of the problem would have been the same in both groups.</p><p>A collaborative approach to optimizing medicine management with the addition of a ward-based clinical pharmacist is effective in providing overall improvement in quality use of medicines and health outcomes in patients with chronic noncommunicable diseases in a Sri Lankan hospital setting. The results of this trial provide an evidence base for policy-makers in Sri Lanka and other low- and middle-income countries to implement ward-based clinical pharmacy services, using local clinically trained pharmacy graduates.</p></sec></body><back><ack><title>Acknowledgements</title><p>We thank N Mamunuwa, V Pathiraja, B Wijayawickrama, patients who participated in this study, the staff members of professorial medical unit, Colombo North Teaching Hospital in Sri Lanka and the members of the Collaboration of Australian and Sri Lankans for Pharmacy Practice Education and Research (CASPPER).</p></ack><fn-group><title>Funding:</title><fn fn-type="supported-by"><p>This work was supported by Australian NHMRC Grant 630650.</p></fn></fn-group><fn-group><title>Competing interests:</title><fn fn-type="financial-disclosure"><p>None declared.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="web">Back ground paper: noncommunicable diseases in low- and middle-income countries. Geneva: World Health Organization; 2010. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/nmh/events/2010/Tehran_Background_Paper.pdf">http://www.who.int/nmh/events/2010/Tehran_Background_Paper.pdf</ext-link><ext-link ext-link-type="uri" xlink:href="http://"/>[cited 2017 May 1].</mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><string-name><surname>Boutayeb</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Boutayeb</surname>
<given-names>S</given-names></string-name>. <article-title>The burden of noncommunicable diseases in developing countries.</article-title>
<source>Int J Equity Health</source>. <year>2005</year> ;<volume>4</volume>(<issue>1</issue>):<fpage>2</fpage>. <pub-id pub-id-type="doi">10.1186/1475-9276-4-2</pub-id><pub-id pub-id-type="pmid">15651987</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="web">PCNE classification for drug-related problems V5.01. Zuidlaren: Pharmaceutical Care Network Europe; 2006. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.pcne.org/upload/files/16_PCNE_classification_V5.01.pdf">http://www.pcne.org/upload/files/16_PCNE_classification_V5.01.pdf</ext-link> [cited 2017 Jul 7].</mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><string-name><surname>Nivya</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Sri Sai Kiran</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Ragoo</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Jayaprakash</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Sonal Sekhar</surname>
<given-names>M</given-names></string-name>. <article-title>Systemic review on drug related hospital admissions - a PubMed based search.</article-title>
<source>Saudi Pharm J</source>. <year>2015</year>
<month>1</month>;<volume>23</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsps.2013.05.006</pub-id><pub-id pub-id-type="pmid">25685036</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="thesis">Gillespie U. Effects of clinical pharmacists' interventions: on drug-related hospitalisation and appropriateness of prescribing in elderly patients [dissertation]. Uppsala: Uppsala University; 2012.</mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><string-name><surname>Stowasser</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Collins</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Stowasser</surname>
<given-names>M</given-names></string-name>. <article-title>A randomised controlled trial of medication liaison services-patient outcomes.</article-title>
<source>J Pharm Pract Res.</source>
<year>2002</year>;<volume>32</volume>(<issue>2</issue>):<fpage>133</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1002/jppr2002322133</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><string-name><surname>Dooley</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Allen</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Doecke</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Galbraith</surname>
<given-names>KJ</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>GR</given-names></string-name>, <string-name><surname>Bright</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal>
<article-title>A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals.</article-title>
<source>Br J Clin Pharmacol</source>. <year>2004</year>
<month>4</month>;<volume>57</volume>(<issue>4</issue>):<fpage>513</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2125.2003.02029.x</pub-id><pub-id pub-id-type="pmid">15025751</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><string-name><surname>Touchette</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Doloresco</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Suda</surname>
<given-names>KJ</given-names></string-name>, <string-name><surname>Perez</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Turner</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Jalundhwala</surname>
<given-names>Y</given-names></string-name>, <etal>et al.</etal>
<article-title>Economic evaluations of clinical pharmacy services: 2006&#x02013;2010.</article-title>
<source>Pharmacotherapy</source>. <year>2014</year>
<month>8</month>;<volume>34</volume>(<issue>8</issue>):<fpage>771</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1002/phar.1414</pub-id><pub-id pub-id-type="pmid">24644086</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><string-name><surname>Mekonnen</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Yesuf</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Odegard</surname>
<given-names>PS</given-names></string-name>, <string-name><surname>Wega</surname>
<given-names>SS</given-names></string-name>. <article-title>Implementing ward based clinical pharmacy services in an Ethiopian university hospital.</article-title>
<source>Pharm Pract (Granada)</source>. <year>2013</year>
<month>1</month>;<volume>11</volume>(<issue>1</issue>):<fpage>51</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.4321/S1886-36552013000100009</pub-id><pub-id pub-id-type="pmid">24155850</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Lucca</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Ramesh</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Narahari</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Minaz</surname>
<given-names>N</given-names></string-name>. <article-title>Impact of clinical pharmacist interventions on the cost of drug therapy in intensive care units of a tertiary care teaching hospital.</article-title>
<source>J Pharmacol Pharmacother</source>. <year>2012</year>
<month>7</month>;<volume>3</volume>(<issue>3</issue>):<fpage>242</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.4103/0976-500X.99422</pub-id><pub-id pub-id-type="pmid">23129959</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><string-name><surname>Babar</surname>
<given-names>ZU</given-names></string-name>, <string-name><surname>Scahill</surname>
<given-names>S</given-names></string-name>. <article-title>Barriers to effective pharmacy practice in low- and middle-income countries.</article-title>
<source>Integr Pharm Res Pract</source>. <year>2014</year>;<volume>3</volume>:<fpage>25</fpage>
<pub-id pub-id-type="doi">10.2147/IPRP.S35379</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><string-name><surname>Perera</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Ranasinghe</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Perera</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Perera</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Adikari</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Jayasinghe</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal>
<article-title>Knowledge of prescribed medication information among patients with limited English proficiency in Sri Lanka.</article-title>
<source>BMC Res Notes</source>. <year>2012</year>
<month>11</month>
<day>29</day>;<volume>5</volume>:<fpage>658</fpage>. <pub-id pub-id-type="doi">10.1186/1756-0500-5-658</pub-id><pub-id pub-id-type="pmid">23191984</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><string-name><surname>Wolf-Gould</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Horwitz</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Barry</surname>
<given-names>M</given-names></string-name>. <article-title>Misinformation about medications in rural Ghana.</article-title>
<source>Soc Sci Med</source>. <year>1991</year>;<volume>33</volume>(<issue>1</issue>):<fpage>83</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/0277-9536(91)90459-P</pub-id><pub-id pub-id-type="pmid">1882245</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><string-name><surname>Perera</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Coombes</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Shanika</surname>
<given-names>LGT</given-names></string-name>, <string-name><surname>Dawson</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lynch</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Mohamed</surname>
<given-names>F</given-names></string-name>, <etal>et al.</etal>
<article-title>Opportunities for pharmacists to optimise quality use of medicines in a Sri Lankan hospital: an observational, prospective, cohort study.</article-title>
<source>J Pharm Pract Res.</source>
<year>2017</year>;<volume>47</volume>(<issue>2</issue>):<fpage>121</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1002/jppr.1302</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><string-name><surname>Shanika</surname>
<given-names>LGT</given-names></string-name>, <string-name><surname>Wijekoon</surname>
<given-names>CN</given-names></string-name>, <string-name><surname>Jayamanne</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Coombes</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Coombes</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Mamunuwa</surname>
<given-names>N</given-names></string-name>, <etal>et al.</etal>
<article-title>Acceptance and attitudes of healthcare staff towards the introduction of clinical pharmacy service: a descriptive cross-sectional study from a tertiary care hospital in Sri Lanka.</article-title>
<source>BMC Health Serv Res</source>. <year>2017</year>
<month>1</month>
<day>18</day>;<volume>17</volume>(<issue>1</issue>):<fpage>46</fpage>. <pub-id pub-id-type="doi">10.1186/s12913-017-2001-1</pub-id><pub-id pub-id-type="pmid">28100204</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><string-name><surname>Hanlon</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Schmader</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Samsa</surname>
<given-names>GP</given-names></string-name>, <string-name><surname>Weinberger</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Uttech</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Lewis</surname>
<given-names>IK</given-names></string-name>, <etal>et al.</etal>
<article-title>A method for assessing drug therapy appropriateness.</article-title>
<source>J Clin Epidemiol</source>. <year>1992</year>
<month>10</month>;<volume>45</volume>(<issue>10</issue>):<fpage>1045</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/0895-4356(92)90144-C</pub-id><pub-id pub-id-type="pmid">1474400</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><string-name><surname>Samsa</surname>
<given-names>GP</given-names></string-name>, <string-name><surname>Hanlon</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Schmader</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Weinberger</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Clipp</surname>
<given-names>EC</given-names></string-name>, <string-name><surname>Uttech</surname>
<given-names>KM</given-names></string-name>, <etal>et al.</etal>
<article-title>A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity.</article-title>
<source>J Clin Epidemiol</source>. <year>1994</year>
<month>8</month>;<volume>47</volume>(<issue>8</issue>):<fpage>891</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/0895-4356(94)90192-9</pub-id><pub-id pub-id-type="pmid">7730892</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="web">World Health Organization. Choosing Interventions that are Cost Effective (WHO- CHOICE); <ext-link ext-link-type="uri" xlink:href="http://www.who.int/choice/country/lka/cost/en/">http://www.who.int/choice/country/lka/cost/en/</ext-link> [cited 2017 Jun 1].</mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="web">Movements of the CCPI - Base. 2006/07 = 100; Department of Census and Statistics &#x02013; Sri Lanka; <ext-link ext-link-type="uri" xlink:href="http://www.statistics.gov.lk/price/ccpi(new)/Movements%20of%20CCPI(200607).pdf">http://www.statistics.gov.lk/price/ccpi(new)/Movements%20of%20 CCPI (200607).pdf</ext-link> [cited 2017 Jun 1].</mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="book"><source>Public Administration Circular 03/2016. Revision of the salaries in public service.</source>
<publisher-loc>Colombo</publisher-loc>: <publisher-name>Ministry of Public Administration and Management</publisher-name>; <year>2016</year>.</mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><string-name><surname>Nielsen</surname>
<given-names>TRH</given-names></string-name>, <string-name><surname>Andersen</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Rasmussen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Honor&#x000e9;</surname>
<given-names>PH</given-names></string-name>. <article-title>Clinical pharmacist service in the acute ward.</article-title>
<source>Int J Clin Pharm</source>. <year>2013</year>
<month>12</month>;<volume>35</volume>(<issue>6</issue>):<fpage>1137</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1007/s11096-013-9837-1</pub-id><pub-id pub-id-type="pmid">23979824</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><string-name><surname>Cornu</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Steurbaut</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Leysen</surname>
<given-names>T</given-names></string-name>, <string-name><surname>De Baere</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Ligneel</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Mets</surname>
<given-names>T</given-names></string-name>, <etal>et al.</etal>
<article-title>Effect of medication reconciliation at hospital admission on medication discrepancies during hospitalization and at discharge for geriatric patients.</article-title>
<source>Ann Pharmacother</source>. <year>2012</year>
<month>4</month>;<volume>46</volume>(<issue>4</issue>):<fpage>484</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1345/aph.1Q594</pub-id><pub-id pub-id-type="pmid">22414793</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><string-name><surname>Hettihewa</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Isuru</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kalana</surname>
<given-names>J</given-names></string-name>. <article-title>Prospective encounter study of the degree of adherence to patient care indicators related to drug dispensing in health-care facilities: a Sri Lankan perspective.</article-title>
<source>J Pharm Bioallied Sci</source>. <year>2011</year>
<month>4</month>;<volume>3</volume>(<issue>2</issue>):<fpage>298</fpage>&#x02013;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.4103/0975-7406.80769</pub-id><pub-id pub-id-type="pmid">21687362</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><string-name><surname>Willoch</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Blix</surname>
<given-names>HS</given-names></string-name>, <string-name><surname>Pedersen-Bjergaard</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Eek</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Reikvam</surname>
<given-names>A</given-names></string-name>. <article-title>Handling drug-related problems in rehabilitation patients: a randomized study.</article-title>
<source>Int J Clin Pharm</source>. <year>2012</year>
<month>4</month>;<volume>34</volume>(<issue>2</issue>):<fpage>382</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s11096-012-9623-5</pub-id><pub-id pub-id-type="pmid">22388601</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="book"><source>Medication without harm - global patient safety challenge on medication safety.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2017</year>.</mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><string-name><surname>Coombes</surname>
<given-names>ID</given-names></string-name>, <string-name><surname>Fernando</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Wickramaratne</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Peters</surname>
<given-names>NB</given-names></string-name>, <string-name><surname>Lynch</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Lum</surname>
<given-names>E</given-names></string-name>, <etal>et al.</etal>
<article-title>Collaborating to develop clinical pharmacy teaching in Sri Lanka.</article-title>
<source>Pharm Educ</source>. <year>2013</year>;<volume>13</volume>(<issue>1</issue>):<fpage>29</fpage>&#x02013;<lpage>35</lpage>.</mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><string-name><surname>Ulmer</surname>
<given-names>FC</given-names></string-name>. <article-title>The Hawthorne effect.</article-title>
<source>Educ Dir Dent Aux</source>. <year>1976</year>
<month>5</month>;<volume>1</volume>(<issue>2</issue>):<fpage>28</fpage>.<pub-id pub-id-type="pmid">1069641</pub-id></mixed-citation></ref></ref-list></back></article>